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C H A P T E R 1 
GENERAL INTRODUCTION 
Epilepsy is an expression of a morbid state of the brain, 
characterized more or less frequently by attacks (clinically 
observable and/or reported by the patient), of which the na-
ture is dependent on internal and external factors. These at-
tacks are always accompanied by deviant electroencephalogra-
phical patterns, whereas in the interictal periods the patient 
is usually feeling normal and one is often missing epilepti-
form discharges in the electroencephalogram (EEG). 
Also epilepsy is a clinical diagnosis. The form in which 
the attack or seizure expresses itself is related to a number 
of factors, like the site of origin of the abnormal discharges 
in the brain and the rapidity of the spread of the discharges 
through the brain. Therefore the term 'epilepsies' can in 
fact be more precisely used. 
Epilepsy is a relatively common disease, probably afflicting 
the human race from the beginning. About a half percent of the 
population throughout the world is suffering from it. Many 
factors like mal development of the nervous system, infections 
of the nervous system, intoxications, noxious stimuli, head 
trauma, brain tumors and degenerative diseases may be causa-
tive, however, the biochemical and physiological backgrounds 
leading to the origin of epilepsy are yet unknown despite in-
tensive investigations. 
The counterpart of clinical seizures may be evoked in labo-
ratory animals. Fritsch and Hitzig (I87O) found that electrical 
stimulation could produce seizures in animals. At present the 
most common methods used to evoke seizures are electrical cur-
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rents and convulsant drugs. A comprehensive review of experi-
mental-induced seizures of several kinds is given by Purpura 
et al (1972). 
The development of antiepileptic drugs is strongly stimula-
ted by experimental studies on animals. In 1912 Hauptmann dis-
covered the antiepileptic efficacy of phénobarbital. Diphenyl-
hydantoin, known since I9O8 when it was synthesized and screen-
ed for hypnotic efficacy by Biltz, appeared to be effective 
against electroshock-induced convulsions in cats (Meritt and 
Putnam, І9З8), but it had a lower hypnotic action compared to 
phénobarbital. In the last decennia many other antiepileptic 
drugs have been discovered, many of them ace identically. The 
mode of action of these drugs is still unknown and while these 
available agents are of great value to the patients, they are 
far from ideal because of the numerous side-effects. 
One of the major side-effects of the three most important 
anticonvulsants — diphenylhydantoin, phénobarbital and pri-
midone — is a decrease of the serum folate level, but the 
source of its origin is still unknown (see chapter 5)· In 
the meantime an increasing number of fits is reported in epi-
leptic patients using folic acid as correction therapy (Cha-
narin et al, I960; Reynolds et al, I968) , but this is also 
disputed by others (Houben et al, 1971; Jensen and Olesen, 
1969; Ralston et al, 1970; Spaans, 1971). Folic acid itself 
is a vitamin with a strong epileptogenic action, extensive-
ly studied in this laboratory by Hommes and Obbens (see 
chapter 6). 
Thus the striking relationship between the epileptogenic 
action of folic acid and a folate-deficiency induced by 
3 
antiepileptics invites the following questions: 
- Is folate-deficiency a side-effect or a principal action 
of antiepilept ics? 
- What role does folate play in the neurophysiology and 
neurobiochemistry of epilepsy? 
In the following chapters first the biochemical background 
of epilepsy will be discussed now. 
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C H A P T E R 2 
NEUROCHEMISTRY OF BASIC MECHANISMS IN EPILEPSY 
It is generally assumed that Ach. has a physiological 
transmitter function on postsynaptic effectors in a part 
of the central nervous system. Ach -neurons may have inhi-
bitory as well as excitatory effects (Kandel 1 and Gardner, 
1972). Calcium ions are necessary for the liberation of 
Ach. If the postsynaptic potential is high enough, the 
transmembrana 1 flows for sodium and potassium are altered, 
resulting in initiation and propagation of an action poten-
tial. This process is normally self-limiting by diffusion 
of Ach. and hydrolytic inactivation by Ach-esterase, the 
enzyme, that splits up Ach. in choline and acetic acid 
in the synaptic cleft. 
Intracarotid, intracisternal and intraventricular in-
jections or local applications of Ach. elicit seizures 
(Maynert, I969)· Inhibition of Ach-esterase can lead also 
to convulsions in consequence of accumulation of the trans-
mitter substance (Baker and Benedict, I968). Atropine, an 
anticholinergic drug which blocks the accessibility of Ach. 
to the receptors, has reportedly both anticonvulsant (Sie, 
I968) and convulsant (Bernard et al, 19&8) properties. The 
drugs bicuculline and Picrotoxin are convulsive as a con-
sequence of an increase in brain Ach-content, but their mode 
of action on these Ach-elevation has to be elucidated 
(Svenneby and Roberts, 197i»). 
5 
Depletion in brain 5-hydroxytryptamine can induce a de­
crease in brain Ach-level (Pepeu et al, 197Ό. 
Observations extended by van Rees et al (I968), mentioned 
by Woodbury and Kemp (1970), showed that dIphenyIhydantoin 
(DPH) in low dosage stimulates the release of Ach. from the 
parasynapthetic nerve endings and intramural ganglia in the 
wall of the isolated rat ileum, resulting in contraction of 
the muscle, but large dosages of DPH are inhibitory by a di­
rect yet unknown action on the muscle. The same dose-depen­
dent Ach-release in brain has been reported by McLennan and 
Elliott (ISSI). 
2. G2utamjc_acjd_—_дагша-аттоЬи tyr]c_açM_ system^ GA—ΐ 
GABA is synthesized presynaptical1 y in the cerebral meta­
bolism to a large extent, if not entirely from GA originating 
from the tricarboxylic acid cycle. The reaction is catalyzed 
by glutamic acid decarboxylase (GAD). The postsynaptical de­
gradation (neuronal cell bodies, dendrites and glial cells), 
consists of the reversible transamination of GABA with alpha-
ketoglutaric acid, catalyzed by an aminotransferase (GABA-T). 
The products of these latter reaction are GA and succinic-
sem¡aldehyde which via oxidation to succinic acid is linked 
with the Krebs-cycle. Within this GABA-shunt the enzymes GAD 
and GABA-T are vitamin B6 dependent (van den Berg et al, 1969; 
van den Berg and Garfinkel , 1971)· 
Lack of this coenzyme of GAD can result in epileptic sei-
zures (Wingo and Awapara, 1950) which can be controlled by 
administering pyridoxine. Inactivating of the coenzyme of GAD 
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¡η animal experiments by several hyurd¿ides, like thiosemi-
carbazide, results also in seizures (Parks et al, 1952), 
which can be promptly stopped by intravenous administration 
of vitamin B6 or by local application (topical or intraven-
tricular) of GABA into the brain (Kil lam et al, i960). Metho-
xypyridoxine, a vitamin Вб-antagonist, lowers the GABA-level 
in brain and causes convulsions (Baxter et al, i960). Dieta­
ry deficiency of B6 vitamers is associated in all mammalian 
species with convulsions which respond promptly to supple­
ments of pyridoxine (see Tower, 1956), but excessive amounts 
of pyridoxine are toxic for the central nervous system (CNS), 
eventually causing convulsions. 
Hayashi (ISS'») observed convulsions after injecting Na-glu-
tamate into the cortex of animals but not when K-glutamate was 
administered. Contrarily, evidence for an inhibitory function 
for GABA at synapses came from studies that established GABA 
as the major factor in brain extracts responsible for the in­
hibitory action of these extracts on the crayfish stretch re­
ceptor system (Bazemore et al, 1957). These inhibitory functions 
of GABA were later confirmed by experiments with iontophore-
tically administered GABA to neurons of the sensorimotor cor­
tex of the cat (Krnjevic and Schv/artz, 1967) and the nucleus 
Deiters (Obata et al, I967). Wiechert and Herbst (I966) sug­
gested that the GA/GABA ratio, determining the cerebral neu­
ronal activity (Elliott and van Gelder, 1958). in rat brain 
is changed in favour of the former in preconvulsive state. 
Gallagher (1971) observed that several forms of vitamin B6 
(pyridoxine HCl, pyri doxal-5~phosphate, pyridoxamine-phos-
phate) lowered the thresholds to the first appearance of a 
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myoclonic jerk and to the appearance of tonic-clonic seizures 
induced by fluothyl. This effect of B6 vitamers may be a con­
sequence of differential stimulation of the enzymes GAD and 
GABA-T. The latter has a higher affinity for vitamin B6, thus 
the resulting change in the GA/GABA ratio may determine sei­
zure activi ty. 
Hassler et al (1970 distinguished two GABA-pools: one me­
tabolic pool with a low turnover rate, present in all nerve 
cells, and one functional pool with a fast turnover rate, pre­
sent in GABA-rich structures. They suggested that the decrease 
in the latter pool is an important pathophysiological factor 
responsible for the production of the self-sustained activi­
ty of nerve cells. In a prospective study Roberts (197Ό 
postulates that GABA may play an important role in a system 
of disinhibition of the CN5. 
There probably exists a link between the GA/GABA ratio and 
sodium (Na)-potassium (K) transport. The uptake of GABA by 
rat cerebral cortex slices is largely reduced when the energy 
supply is decreased in tissue (Battistìn et al, 1969)t more-
over the uptake process seems to be Na-dependent (lversen and 
Neal, I968). Krnjevic (1970) proposed a carrier-mediated 
system for membrane transport of Na and glutamate together. 
Arnfred and Hertz (1971) found that the influx of glutamate 
and efflux of glutamate and tracer-GABA in brain slices are 
influenced by excess К in the medium. Glutamic acid reduced 
ATP levels strongly in neurons of rat brain slices (Gruener, 
I972). The uptake of tracer-GABA by penicillin focus is de­
creased (Gottesfeld and Elazar, 1975) as there is a rise in 
extracellular К in penicillin focus (Moody et al, ^Э7^*). 
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GA caused an increased entry of Na „ a ornali !< 'ess tc the 
extracellular space, diminution of energy rich phosphates and 
an increase in tissue respiration (Harvey and Mcllwaîn, I968). 
Cobalt application to the frontal cortex of cats reduced 
the concentrations of taurine, glutamate, aspartate and GABA 
at the epileptogenic focus (Koyama, 1972). Craig and Hartman 
(І97З) observed the same decrease in amino acids in rats 
rendered epileptic by means of cobalt-wire implants into the 
cortex. 
A possible relation between antiepiSeptics and the GA-GABA 
system has been recently studied in detaii. Saad et al (1972) 
and Saad (1972) observed an increase of GABA in the cerebral 
hemispheres of mice after intraperitoneal administration of 
DPH, phénobarbital and diazepam. This effect was more pro-
nounced when the cerebral hemisphere content of GABA was re-
duced previously by isoniazid. The GABA level of rat brain 
— the cerebellum was dissected before analysis — w a s un-
affected by trimethadionep ethosuximide or chlordiazepoxide, 
but a significant decrease ir GA level could be observed after 
trlmethadione treatment (Nahorski, 1972). Tappaz et al (1973) 
found a significant decrease in GA content of rat brain after 
DPH treatment whereas phénobarbital, trimethadione and etho-
suximide had no effects, in i960 Ve^nadakis and Woodbury ob-
served a decrease in GA and increase 'n GABA of rat brain by 
DPH but it appeared that the latter process was much more pro-
nounced in adrenalectomized rats. Because of various methods 
and various results definite conclusions about antiepilept ics 
on the GA-GABA system cannot yet be drawn. 
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3· Ççr§bra2_e2eçtrg2yte_metabgl[sm 
The energy-dependent 'pumping' of Na and К across the ex­
citable membrane maintains the appropriate differential dis­
tribution of Na and К required to support excitation. In this 
'pumping' process the Na-K-dependent adenosinetr¡phosphatase 
(ATP-ase) possesses a central role. Robinson (1970 has pro-
posed a reaction mechanism for Na-K-ATP-ase, which includes 
firstly the binding of the terminal phosphate of ATP on the 
gamma-carboxylgroup of L-glutamic acid within the enzyme ATP-
ase in the presence of Na and magnesium (Mg). In the absence 
of К this complex is fairly stable, but in the presence of 
К intramolecular migration of the terminal phosphate from 
glutamate to serine occurs. The latter is a quite labile com­
plex. In this connection it is of interest that folylpolyglu-
tamates have also one or more gamma-carboxylgroups of gluta­
mic acid. 
Hillman (1970) proposed that epileptic attacks may be 
caused by increased permeability to Na- and K-ions of mem­
branes in a localized group of cells, resulting in a reduction 
of transmembrane ionic gradients. Firing of the cellgroup 
follows. The resultant increase in extracellular K-ion con­
centration causes other cells in the region to fire, and 
the focus spreads. However, Viukari (1972) proposed that the 
epileptic mechanism is composed of an excessive Na-influx 
and a relative lack of К which consequently results in an 
impaired activity of cellmembrane ATP-ase. 
Intracerebral injections of ouabain, a cardiac glycoside 
that inhibits Na-K-ATP-ase (Swanson and Mcllwain, 1965), 
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can generate generalized seizures (Bignami and Pal ladini, 
I966; Lewin, I97O; Donaldson, 1971). Ouabain induces respi­
ration increase dependent upon the presence of calcium ions 
(Ca), increase in intracellular Na and decrease in intra­
cellular К in cerebral cortex slices (Swanson and Ullis, 
I966). An increase in Ca-content of ouabain-treated cerebral 
slices and the subcellular mitochondrial fraction, prepared 
from such slices, was found by Tower (I968) and Stahl and 
Swanson (I969). 
Hunt and Craig (1973) studied the cation levels and Na-
K-ATP-ase in cobalt-induced epilepsy in the rat and observed 
in the area of the lesion itself a marked increase in Ca-, M,g-
and Ha-contents together with a decrease in K-content and Na-
K-ATP-ase activity. Later, also significant changes in cere­
bral cortical lipids were found (Cenedella and Craig, 1973). 
Zuckerman and Glaser (1970) were able to activate latent 
epileptogenic foci in the dorsal hippocampus of cats with in­
creased К in the extracellular spaces of the brain. The la­
tent period before activating, they suggested, is due to the 
presence of protective barriers (glial cells and macromole-
cules) which could prevent K-accumulat¡on in the extracellu-
lar spaces. According to the theory of Viukari (1972) the 
extracellular K-accumulat ion could induce an impairement of 
the Na-K-ATP-ase. In a later study Zuckerman and Glaser (1973) 
observed a strong anticonvulsant action of Ca on electrical 
stimulation, perfusion of K, penicillin, pentetrazole, L-glu-
tamate and a combination of Ach. and edrophonium (an Ach-
esterase inhibitor), the result, they assume, is probably due 
to blocking of the action of К by Ca. Swanson (1972) already 
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suggested that the epileptogenic action of penicillin, besides 
reduction of creatinephosphatase and ATP, depression of respi­
ration rate and reduction of lactate formation, could result 
from leakage of intracellular К with secondary effects on 
other regions. Lebovitz (IS?**) found an inversed relation be­
tween ouabain concentration in the perfusioni luid and the on­
set of acute acceleration of spontaneous interictal discharges, 
evoked by penicillin. Thus the question arised if an increase 
in extracellular К could be responsible for generating con­
vulsions in the pathophysiology of epilepsy, but Lux (197M , 
recording intracortical K-activity using K-specific micro-
electrodes during seizures, electrically induced in cats, 
concluded that the increase in extracellular К is a result 
rather than a cause of epileptiform activity. Also Moody et 
al (197*0 using the same recording technique, stated that 
the extracellular К did not appear to be a critical factor 
in initiation or termination of seizures. He also mentioned 
that in the same laboratory other experiments indicated that 
In the rabbit cortex, ictal activity can occur within a wide 
range of extracellular K. 
Large doses of zinc and copper, divalent tracer metals 
which can inhibit Na-K-ATP-ase, are able to evoke seizures 
when injected intraventr¡cularly (Donaldson et al, 1971). 
Increased copper levels (Brunia and Buyze, 1972) and de-
creased zinc levels (Barbeau and Donaldson, 19710 have been 
found in treated epileptic patients, matched and unmatched 
to sex and age respectively. These metals also produce a 
substantial increase in the cerebrospinal fluid (CSF)-K-
level (Donaldson et al, 1972). Taurine, a non-essential ami-
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no acid, found to be lowered in the locus of maximal epilep­
tiform activity in human patients (van Gelder et al, 1972), 
has an anticonvulsant activity in cobalt-induced epilepsy in 
cat and mouse (van Gelder, 1972), in photosensitive epilepsy 
in Papio papio (Derouaux et al, 1973), but also against oua-
bain-induced seizures in rats (Izumi et al, 1973a). In zinc-
deficient animals the taurine level of a tracer dose is ele­
vated in the urine (Anthony et al, 1971)· Barbeau and Do­
naldson (197*0 reviewed the relationship between GABA, zinc, 
taurine, Na-K-ATP-ase and epilepsy, and proposed a key role 
for a defect in zinc metabolism within this relation. Pre­
liminary experiments and their own results justify con­
trolled therapeutic trials of taurine, they postulated. In 
this connection it is remarkable that weanling rats exposed 
to zinc depletion for 6 weeks showed a decreased liver fo­
late content which did not seem to be mediated by vitamin 
B12 (Williams et al, 1973). 
In 1955 Woodbury suggested that UPH exerted its anticon­
vulsant action by facilitating the active Na-transport to 
the extracellular space. Also in non-excitable tissue an 
influence of DPH on Na-transport could be demonstrated 
(van Rees et al, 19б9)· The observed stimulation of Na-K-
ATP-ase by DPH, dependent on the Na-K-ratio, in synapto-
somes isolated from rat cerebral cortex (Festoff and Appel, 
I968; Lewin and Bleck, 1971) tends to confirm this concept 
of membrane stabilization by DPH. It seems that other mecha­
nisms than 'pumping' are at least in part responsible for the 
stabilizing effect of DPH. Pincus et al (1970) found that DPH 
does not affect intracellular Na in normally functioning oxy-
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genated cells, as It does in hypoxic cells. Moreover DPH li­
mits the rise in intracellular Na in cells in which the Na-
extrusion mechanism has been destroyed by ouabain. They postu­
lated that DPH limits Na-influx during stimulation rather than 
enhancing Na-extrusion. A later study of Plncus (1972) about 
ion-fluxes in DPH-treated lobster nerves supports this hypo­
thesis. Escueta et al (197*0 however suggested that DPH con­
trols epileptic seizures by stimulating K-uptake within sy­
naptic terminals: DPH stimulates the Na-K-pump and a second 
unknown K-uptake process, Insensitive to ouabain. 
In 195^ Chen et al observed a lowered threshold for elec-
troshock-induced seizures in mice, in which the central mono­
amines noradrenaline (NA), dopamine (DA) and S'hydroxytrypta-
mine (5~HT) had been depleted by reserpine. No differentiation 
was made between these biogenic amines. Jobe et al (1973a,b) 
found a consistent relation between increased audiogenic sei­
zure severity and drastically reduced levels of NA and 5-HT 
but not of DA. However, in a later study of Jobe et al (УЭТ1*) 
using the electroshock-induced seizure model, they suggested 
an Inferior role of 5-hT in contrast with the role of NA and 
DA. This suggestion is In partial disagreement with the study 
of Kilian and Frey (1973), who stated that NA and 5-HT, but 
not DA, is of importance in electroshock-induced seizures in 
rats and mice. On the contrary,the threshold for the clonic 
component of pentetrazole-induced seizures seemed largely to 
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be mediated by NA, whereas in the threshold of the tonic com­
ponent of these convulsions NA and DA played no crucial role 
as contrasted to 5~HT. De la Torre (1970) demonstrated a re­
ciprocal relationship between rat brain 5-HT level and neu­
ronal excitability induced by pentetrazole. Recently Kovacs 
and Zoll (197Ό showed that electrical stimulation of the 
median raphe nucleus inhibits generation of seizures, induced 
by pentetrazole or daily electrical stimulation of the amygda­
la at subselzure level until the occurrence of a full clonic 
seizure. The midbrain raphe has in the perikarya and the axon-
terminals of its neurons a very high concentration of 5~HT 
(Dahlström and Fuxe, 1965; Palkovits et al, 1971»). The ascen-
ding, descending and cerebellar 5~HT projections from the mid-
brain raphe cell groups can be divided in a lateral cortical 
5-HT pathway primarily innervating the cortex cerebri, a me-
dial subcortical 5-HT pathway primarily innervating the hypo-
thalamus, preoptic area and cortex cerebelli, and a far la-
teral 5-HT pathway primarily innervating the extrapyramidal 
motor system (Fuxe and Johnson, 197*0. The action of 5-HT, 
applied microiontophoretically to firing cerebral cortical 
neurons, is predominantly inhibitory (Jordan et al, 1972) 
and cortical evoked potentials are inhibited by raphe sti-
mulation (Samanin, 1972). Klawans et al (1973) however re-
ported 5-hydroxytryptophan (5-HTP)-induced myoclonic sei-
zures. Westheimer and Klawans (197*0 observed potentiation 
of subthreshold doses of 5-HTP by Imipramine, an inhibitor 
of the reuptake of 5-HT in the brain, leading to myoclonic 
seizures. Ouabain intraventricularly increases significant-
ly 5-HT in the hippocampus and decreases significantly NA in 
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the midbrain region (Izumi et al, 1973b). 
The relationship between anticonvulsants and central mono­
amines is also very obscure. In an in vitro study of Hadfield 
(1972) it was shown that DPH may change the neuronal uptake 
of rat brain catecholamines, in which the oxygenation process 
plays an important role. In a later in vivo study this was 
substantiated (Hadfield and Boykin, 197^К Also Azarro et al 
(1973) were able to inhibit intracellular NA-accumulation 
with high concentrations of DPH, whereas low DPH concentra­
tions showed facilitation of intracellular NA-accumulatlon 
and reduction of the oxidative catabolism of NA. A signifi­
cant rise of total brain 5-HT was seen after DPH administra­
tion (Bonnycastle et al, 1962; Anderson et al, 1962). Ρ i neus 
and Lee (1973) demonstrated reduced NA-release from brain 
slices after DPH, but increased NA-release by K. DPH also 
inhibited the intracellular uptake of Ca, that has to be pre­
sent in the NA-releasing process (Baldessarini and Kopin, 
I967). Meyer and Frey (1973) observed that the anticonvul­
sant effect of phénobarbital against electroshock-induced 
seizures was dependent on 5-HT and NA, whereas in the anti-
convulsant efficacy of DPH the role of 5~HT remained doubt-
full. In the pentetrazole seizure threshold test only 5-HT 
was essential in the anticonvulsant efficacy of phéno-
barbital. Recently Shaywitz et al (1975) measured the CSF 
level of 5-hydroxyindoleacetic acid (5-HIAA) and homovanil-
1ic acid (HVA) in a group of epileptic children on anti-
convulsant medication and in a control group without epilep-
sy ((probenecid — ^-(dipropyl-sul famyl ) benzo i с acid — was 
administered to both groups}. The concentrations of both 
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amine metabolites were significantly lower in the epileptic 
children (probenecid concentrations were similar in both 
groups), but not related to age, anticonvulsant medication, 
CSF-folate, CSF-protein or CSF-cell count. Strikingly were 
the inversed findings of Chadwick et al (1975). They observed 
a significantly raised level of 5-HIAA and HVA in the CSF of 
anticonvulsant-treated epileptics compared to untreated epi­
leptics and controls with other neurological illnesses. In 
patients, intoxicated by anticonvulsants, the rise in the CSF 
level of biogenic amine metabolites was most pronounced. More­
over, they demonstrated a close correlation between 5-HIAA and 
HVA level in the CSF, especially in the treated epileptics. 
Green and Grahame-Smith (1975) suggest that DPH stimulates 
the rate of 5~HT-synthesis without affecting the reuptake. 
5· Co? §І ble_2 η te r rel^atjgn s h]gs_gf_ neuro transmit ter s_and 
Ach. 
Spector (1972a), observing an increase in muscle contraction 
of rat's heart and musculus gastrocnemius following nerve sti­
mulation in the presence of folate, proposed that folate can 
act as a 'secondary transmitter' for Ach. The used folate de­
rivatives were folic acid and formyltetrahydrofolate. The 
antagonistic effects of DPH, he suggested, could be due to a 
competition between folate and antiepileptic drugs for cal­
cium binding sites in the cell membrane (see also Jenkins 
and Spector, 1973). Facilitating effects of folates on firing 
of Ach-excitated neurons in cat's cortex in vitro were found 
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by Davìes and Watkins (1973). 
GA-GABA 
Folic acid and 5-formyltetrahydrofolate have power-
ful facilitating effects on firing of spontaneously active 
or GA-excitated neurons in cat's cortex in vitro. In this 
respect 5-formylTHF was more effective. In quiescent neu-
rons, that were not GA-excitated, these folates exhibited 
only very weak effects, but 5-formylTHF appeared to be again 
more powerful. The depressant action of GABA was strongly 
reduced by these compounds (Davies and Watkins, 1973). 
Obbens (1973) postulated a carrier function of folate dé-
rivâtes in neuronal membranes for Na and GA, but Roberts 
(197Ό observed an Inhibition of GA-uptake in glia cells 
by folic acid, 5-formylTHF and methotrexate (a fo.ate-anta-
gonist). DPH did not affect the inhibition of uptake by 
folic acid, but influence of DPH on Inhibition by thé other 
compounds is not reported. In a later study (Roberts and 
Watkins, 1975) folic acid appears to inhibit also the GA-
uptake in synaptosomes of rat cerebral cortex. Similarly, 
glial and synaptosomal uptake of GABA Is reduced by folic 
acid. 
Electrolytes 
Besides the suggested interaction of membrane bound Ca 
and folates (see above Spector, 1972a; Jenkins and Spector, 
1973), no data as far as the literature is concerned, are 
yet available on relationships between folates and other 
electrolytes. 
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Central monoamines 
Hoir et al (1971) found no influence of folic acid admi-
nistration on CSF level of HVA and 5-HIAA in dogs, but Hunter 
et al (I97I) observed in volunteers a significant fall in 
the CSF-HVA level after a single oral dose of 30 mg folic 
acid. No significant fall in 5~HIAA and no increase of fo-
late in the CSF could be demonstrated, while patients on 
anticonvulsant medication showed a less though not signi-
ficant fall in the CSF-HVA level. The 'secondary transmitter' 
function of folates should apply also to NA because of the 
observed enhancement by 5"formy1THF of tissue respiration 
stimulated by NA in rat brain synaptosomes (Spector, 1972b) 
and in rat's heart, ileum, virgin uterus and kidney (Spector, 
1972a). One of the most important papers written is the re-
port of Leysen and Laduron (197^) who postulated that 5~ 
methylTHF is very likely the primary methyldonor for the 
most occurring N-methylation of the biogenic amines, while 
S-adenosylmethlonine (SAM) must be reserved as methyldonor 
for the O-methylation. N-methylation is probably a very 
active process in the brain. Mandel 1 et al (1971») suggested 
that the methyltetrahydrofolate—tryptamine N-methyltrans-
ferase plays a role in serotonin inactivation in brain. 
Reports written over the possible role of folates in 
neurophysiology and neurobiochemistry are hard to find, al-
though it is possible to assume that the folates, especially 
the methylated forms may have a central role between neuro-
transmitters on the one side and antiepileptic drugs on the 
other side. 
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C H A P T E R 3 
DIPHENYLHYDANTOIN (DPH) 
o!?§2rPíÍ2D.i_íJ.Í§Ír.ÍÍ!yÍÍ2D_§DíLÍ?l9ír§D§Í2r!!!§ ÍÍ9D 
Diphenylhydantoin 
A comprehensive review of DPH 
metabolism in mammalian spe-
cies is given by Woodbury et 
al, 1972. 
The intestinal absorption is 
mainly rapid, passive and In 
the non-ionized form In the 
duodenum. After entering the 
bloodstream DPH Is rapidly 
and reversIbly bound to pro-
teins (in human about 90%). The remainder free unbound frac-
tion moves at a high rate into the body cells. Higher con-
centrations of DPH are found in cells than in extracellular 
fluids, due to binding on subcellular fractions, since the 
concentration of free DPH in all body tissues is the same 
as that in plasma. DPH in the free form enters also Into 
'transcellular' fluids (like CSF) where the concentration 
is equal to the unbound plasma fraction. Human therapeuti-
cal levels In plasma ranges generally from 10 - 15 microgr/ml, 
Unreliable intake and underdosage are important causes of 
Ineffective low total plasma levels. The brain concentration 
Is equal to the total plasma DPH concentration. In the squir-
rel monkey the DPH content of the white matter is 2 - 3 times 
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higher than of the gray matter (van der Kleyn et al, 1972), 
while in the neuronal fraction of rat brain a much higher 
DPH level is found than in the glial fraction (Yanagihara, 
I972). Binding capacity should be directly related to brain 
protein content and independent on time (Goldberg and To-
doroff, І97З) in contrast with the findings of Kemp and 
Woodbury (I971) concerning increasing specific microsomal 
time-dependent binding. Saturation of binding sites Is es­
sential before stable plasma and tissue levels can be reach­
ed. The plasma half-life in human varies from 7 - ^2 hours 
depending on the dose and way of administration. The range 
of the 0PM plasma clearance from a lower dose to a normal 
therapeutical dose is characteristic of a first-order pro­
cess, but a saturating dose occupies completely the drug meta­
bolizing enzymes resulting in the plasma clearance of a zero-
order process (e.g. with ethanol; Vree et al, 1975) with a 
maximum enzyme capacity (Vmax.). Thus a longer hal f-li fe 
appears in comparison to the first-order elimination pro­
cess, which gives the range found by several authors. The 
plasma half-life can easily be altered by drugs that com­
pete for binding or inhibit/accelerate biotransformation in 
the liver. The biotransformation is species-dependent, but 
consists to a large extent of parahydroxy!at ion (in human 
about 60 - 80%, dose-dependent), at which 5-(p-hydroxyphe-
nyl)-5"phenylhydantoin (p-HPPH) is formed by cytochrome 
P-450. Thereafter it is excreted as a glucuronate into the 
bile, subsequently nearly all is reabsorbed into the blood 
and excreted Into the urine (enterohepatic recycling). For­
mation of p-HPPH inhibits the further hydroxylation of DPH. 
Central nervous »y·tem 
Peripheral nervous system 
Epfdcrval reaction» 
Cardlo-vesculer dliturbance« 
Cestro- lntet t lnal disturbances 
Liver disease 
Genlto-urlnary disturbances 
Blood dyscraslas 
Endocrine disturbances 
fllscetlaneoua 
ataxia 
bradyklncsia 
cerebellar degeneration 
dizziness 
drowsiness 
dysarthria 
epilepsy (Increases the frequency of absences) 
headache 
nystagmus 
personality changes 
psychotic disturbances 
tremor» 
accommodation disturbances 
amblyopia 
diplopia 
neuropathy 
ophthalmoplegia 
alopecia 
exfoliative dermatitis (rare) 
hypertrichosis 
skin rashes 
Stevens-Johnson syndrome 
cardiac errest (on Intravenous Infusion) 
myocardial damage 
abdominal pain 
anorexia 
constipation 
nausea 
vomiting 
hepatic necrosis 
hepat i t is 
hepato- and Splenomegalie 
albuminuria 
hematuria 
herna toporphyrI nur Ia 
thecoma of the ovary 
agranulocytosis 
aplastic anemia 
eoslnophlI la 
IeucopenIa 
megaloblastic anemia 
pancytopenia 
thrombocytopenia 
chloasma 
Increased hydrocortlsol excretion 
Inhibited Insulin release 
decreased proteInbound Iodine 
blth defects, especially che)lopelatoschlzls 
fever 
folic acid deficiency (teratogenic?) 
gingival hyperplasia 
Itmnunodepresston 
lympadenopathy 
periarteritis nodosa 
potyarthropathy 
systemic lupus erythematosus 
Table 1 DPH side-effects ( Meinardi and Stoel, 1974 ). 
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Ashley and Levy (1973) demonstrated that elimination of sa-
turating doses of DPH in rats is quantitively consistent 
with this product-inhibítion. Self-induction of hydroxyla-
tlon by DPH does not seem to occur. Age, sex and body size 
should always be fully considered in the clinical interpre-
tation of data obtained by periodic monitoring of plasma 
DPH levels (Sherwln et al, \Э71*; van der Kleyn et al, }S7t*; 
van der Kleyn et al, 1975; Guelen et al, 1975). 
Meinardi and Stoel (197M have extensively reviewed DPH-
induced dose-dependent and allergic disturbances (table 1). 
The dose-dependent side-effects occur at plasma levels or­
dinarily above 15 microgr/ml. In the last few years DPH-in-
duced disturbances of calcium-and bone-metabolism have been 
reported (see Kraft et al, 1971*) , but long term prophylac­
tic administration of vitamin D may be benificial (Kraft et 
al, 1971»). Prolonged treatment with DPH tends to show an in­
creased excretion of copper In the urine, due to chelate for­
mation (Peters et al, I966). DPH can reduce vitamin K-depen-
dent coagulation factors (Solomon et al, 1972). A contro­
versial toxic effect Is the DPH-encephalopathy.characte­
rized by increasing seizures accompanied by electroencephalo-
graphical changes, alterations in mental functioning and 
motor/sensory disturbances, in human as well as in labora­
tory animals (see Bazemore and Zuckermann, 197Ό, but the 
study of Bazemore and Zuckermann (197Ό makes it very like­
ly that DPH-lnduced seizures occur only when other causative 
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factors such as anoxia, metabolic derangement, drug-withdra-
wal, an underlying epileptic disorder or probably irregular 
plasma levels are present, because of the fact that they 
could not observe DPH-induced seizures in normal animals but 
only clinical seizure-like episodes without electroencepha-
lographic seizure-activity. Moreover the electroconvulsive 
threshold was raised during the development of acute OPH-
intoxlcation and is maintained at high levels during chro-
nic intoxication. In addition, DPH did not enhance pente-
trazole-induced seizures, as suggested by others. DPH-indu-
ced cerebellar degeneration, especially of the Purkinje 
cells (see Glaser, 1972) might also be responsible for loss 
of seizure control. In this connection it is of Interest 
that Cabreéis (1970) made acceptable that the anticonvul-
sant efficacy of DPH is partly due to its direct stimulation 
of the metabolic activity of Purkinje cells and that Cooper 
et al (1973) observed an inhibition of a cortical cerebral 
epileptic focus by stimulation of the cerebellar cortex. To 
what extent DPH-induced disturbances in folate metabolism 
may be responsible for toxic effects and allergic reactions 
of DPH treatment, remains unclear until now. Dementia, neuro-
pathy, cerebellar and bone-marrow disturbances are usually 
associated with derangements of folate metabolism in DPH 
treated epileptic patients. 
ÍD^Í£5ÍÍ9DS_Í9f_9?b_Sr?aí!PSDÍ 
Indications for DPH treatment are grand mal, focal sen-
sory and motor, and psychomotor seizures. DPH Is ineffective 
2Ц 
against petit mal seizures, febrile convulsions in children 
at low age, and convulsions due to withdrawal of short-acting 
barbiturates. The point of action, however, has to be deter­
mined precisely. 
Ь?УЕ2Р!?¥§.І9І29ІС5І_§§І?Е£І5 
Stille (1955), observing inhibition of polysynaptical re­
flexes by DPH, concluded that DPH operates upon interneurons. 
He suggested that DPH could influence the excitability of the 
CNS by affecting neurons of the formatio reticularis. Espi in 
(ISS?) reported that DPH could reduce the posttetanlc po­
tentiation In the spinal cord of decerebrated cats. Postte­
tanlc repetitive after-discharges in the motor nerve of cat's 
musculus soleus abolished under influence of DPH (Raines and 
Standaert, I969). Both posttetanic phenomena are thought to 
be caused by posttetanic hyperpolar¡zation of the presynap-
tic terminals. High frequent repetitive discharges of an epi-
leptogenic focus may cause posttetanic potentiation,by which 
cortical spread of focal firing can be explained. Inhibition 
of posttetanic hyperpolarizatlon by increased DPH-Induced cel-
lular Na-extrusion could explain this ant¡spreading activity 
of DPH on seizure discharge (Woodbury and Kemp, 1970), but 
the same authors proposed also other possible anticonvulsive 
mechanisms: hyperpolarizatlon of the postsynaptic membrane 
and inhibition of Increased Ca-permeabiI Ity as a result of 
the tetanic process. Morel 1 et al (1959) observed a preven-
tion of the spread of a ethylchlor¡de-activated focus to the 
contralateral side without affecting the focus Itself. Louis 
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et al (I968, 1971) observed In penicillin-Induced cortical 
foci a lack of correspondence between electrocortical dis­
charges and clinical jerking after ΟΡΗ treatment. They con­
cluded that DPH blocks afferent and efferent pathways from 
epileptogenic cortical tissue, and assumed that DPM affects 
neuronal structures below the level of cortical dendrites. 
Sherwin (І97З) found a direct but differential cortical lo­
cus of action of DPH: the pyramidal tract respons waves 
representing re-excitation of pyramidal tract cells by re­
petitive stimulation via intervening cortical înterneurons 
are much more inhibited by DPH than waves representing the 
direct excitation of Betz cells. He also suggested that 
those responses that depend on repetitive activity in poly-
synaptic mechanisms are much more sensitive than those de-
pendent on olIgosynaptic mechanisms, and that the observed 
differences are probably due to the suppression of postte-
tanic hyperpolar¡zat Ion by DPH. In cobal t-eptleptogenic foci 
DPH did not influence the number of single spikes in the vi-
cinity of the focus in rat's cortex (Chocholova and Radei, 
І97З). They observed an enhancement of the number of gene­
ralized episodes (groups of spikes with a frequency of 
8 - 9/sec.). Simultaneously the frequency of spikes within 
such an episode decreased significantly. Higher doses of DPH 
caused suppression of the typical episodes and substitution 
by spindle-like formations of slower frequency ( 5 ~ 6/sec) 
bearing no spike-like features. The tonic phase of maximal 
electroshock seizure is completely reduced by DPH (Toman, 
19^9; Woodbury and Esplín, 1959) but DPH affords no protec-
tion against pentetrazole-induced seizures (Morel 1 et al, 1959)· 
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C H A P T E R k 
BIOCHEMISTRY OF FOLIC ACID 
Occurrence 
Folic acid or pteroylmonoglutamic acid, one of the B-
vitamins, was first isolated in crystalline form out of spi­
nach leaves ( Mitchell et al, УЭ1*)) · In 19^6 Angier eluci­
dated the chemical structure and synthesized folic acid. 
Folates, the general term for folic acid and its dérivâtes, 
are mainly present in food in the form of folylpolygluta-
mates (Butterworth et al, 1963), that is to say, 1 - 6 L-
glutamic acid molecules are combined by means of gamma-
carboxy linkages with the glutamic acid moiety of folic 
acid. 
H0N 
Folicjïcid [p^roylrTi£noglutamic_acid2 
OH or polyjgamma g lu tamy l | n glutamic acids 
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I -CH3 at N5 methyl 
\—CHO at N5 or Nig formyl . 
\ > some folate derivatives 
j-CH^ at N5 or N10 methyleen I 
' - C H - at N 5 Ию methenyl 
N 
78 di hydro 
Y® reduction state of folates 
5,6,7,8, tetrahydro 
The folates generally exist In nature bound to proteins 
(Iwai et al, Ι96Ό· Very high contents of folates are found 
in liver, yeast and leafy vegetables. The estimated human 
daily requirement for folic acid varies from 50 microgram 
(Herbert and Bertini, 1967) to 100 microgram (Chanarin et 
al, I968), but is elevated in pregnancy, infection and in­
creased cell turnover. Body folate stores will last 3 - 6 
months after cessation of the supply of new folates (Her­
bert, 1967). 
In the lumen of the small intestine the gamma-carboxy 
linkages of the dietary folylpolyglutamates are severed by 
gamma-L-glutamyl-carboxypeptldase (Butterworth et al, 1969; 
Baugh et al, 1971), an enzyme that attacks the L-termi nal 
glutamic acid residue, when both carboxyl groups are free 
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(Kazenko and Laskowski, 19^8). Such deconjugating enzymes 
have been found in the intestinal mucosa (Rosenberg et al , 
1969), in plasma (Wolff et al, 19^9) which hydrolyses the 
gamma-glutamyl peptides of the folylpolyglutama tes in the red 
blood cells during autolysis of blood, and in many mammalian 
tissues like liver, pancreas, kidney, spleen and brain (Mims 
et al, I9M, 19^5; Bird et al, 19^6; Kazenko and Laskowski, 
19^8). The site of absorption of the folates is the proximal 
part of the small intestine (Hepner et al, I968). There is 
a rapid and nearly complete absorption of orally given phy­
siologic doses of folic acid (Anderson et al, i960), but it 
is yet questionable whether this is a carrier-mediated pro­
cess. Grossowicz et al (1973) fed rats with 'natural' food 
folates using the livers of other rats (fed with labelled 
folic acid) as source and found that absorption of liver 
folate was more efficient than that of crystalline folic 
acid, while absorption was not affected by the folate status 
of the animal. The more liver eaten, the higher the serum 
folate level was. Strum et al (1970), using the mucosal scra­
pings from the small bowel of rats, showed that the uptake 
of 5-methylTHF increased with increasing concentrations. 
These findings, above mentioned, indicate a passive trans­
port mechanism, but other findings pointed out a carrier-
mediated process. Leslie and Rowe (1972) were able to isolate 
from the brush border of rat jejunal mucosal cells a protein, 
that has a specific folate-binding capacity. Weir et al 
(І97З) found that of the chemically inseparable diastereo-
isomers of 5-methylTHF the absorption of the naturally oc­
curring isomer, which was made radioactive, was greater, but 
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¡η four patients with coeliac disease the absorption oP the 
naturally occurring substance was in the same range as the 
biologically inactive form. Lanzkowsky et al (1969) aes-
cribed a patient with a specific isolated congenital folate 
malabsorpt ive defect. Recently however^ Blai r et al (1971*) 
suggested a new mechanism for folic acid transport, in which 
folic acid is converted to the non-ionized form at the mu­
cosal surface in an acid microclimate. 
Also some controversy exists with regard to the degree 
of reduction and methylation of the pteridine nucleus during 
absorption. Baker et al (1965) found that folic acid was 
altered to 5~methylTHF during its transport through the in­
testinal mucosa cells, but they could not exclude the parti­
cipation of the liver. Melikian et al (1971) concluded that 
conversion of folic acid to 5-niethylTHF occurred mainly in 
the liver because they were not able to show a rise in the 
5-inethylTHF level of portal vein catheterized blood after 
orally administered folic acid. Recently Perry and Chanarin 
(І97З) using an isolated everted sac of the rat gut sup­
ported evidence that folic acid during its passage is for-
mylated and methylated. However, Weir (197*») remarked that 
the question is to a large extent academic since dietary 
folates are mostly reduced methylated fol у 1 monoglutamates 
after deconjugation, which is entirely different from folic 
acid. 
The intestinal microflora is capable (unlike humans) of 
synthesizing folic acid when provided with the necessary 
building blocks. In the rat folic acid may be obtained 
through the ingestion of its fecal matter (coprophagy) , but 
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Sulfonamide can block bacterial synthesis of folic acid by 
inhibiting incorporation of paraaminobenzoic acid (Jukes and 
Broquist, І96З). 
Вjoçhemjçaj_function 
In many metabolic processes folates are coenzymatically 
involved, transferring one-carbon units. The most important 
processes are: 
- purine synthesis 
- thymidylate synthesis 
- interconversion of amino acids 
a. serine — glycine (vitamin B6 dependent) 
b. homocysteine—methionine (vitamin B12 dependent) 
c. histidine—glutamic acid (FIGLU-test) 
- hydroxylation of tyrosine and tryptophan which requires 
pteridine co-factors. Thus catecholamine and indoleamine 
metabolism 
- N-methylat ion of monoamines in the brain 
The determination of the folate derivatives is a micro-
biological estimation with the Lactobacillus casei and the 
Streptococcus faecal is. The first one responds to the mono-, 
dì- and triglutamate derivatives, whereas the last responds 
to the mono- and diglutamate forms with the exception of the 
methylated ones (Shiota, 1970). The folylpolyglutamate con-
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centration with more than three glutamic acid molecules 
can be determined with the same bacteriological mediums 
before and after treatment of the biological sample with 
gamma-L-glutamy]-carboxypeptidase. Although the micro­
biological assay alone is a satisfactory but time-consuming 
assay, this procedure does not permit an identification of 
the various derivatives of folate, particularly in the case 
of folylpolyglutamates. If such information is desired, the 
use of chromatography on TEAE or DEAE cellulose columns 
permits a much more satisfactory differentiation of folate 
derivatives (Bird et al, 1965). A comprehensive review of 
the microbiological assays is given in chapter 8. 
Cgntents_of_bgdy_flu]ds_and_tjssues 
The total body content of folates in human amounts 
12 - 15 mg. (To day's Drugs, ІЭб1»). It Is suggested that 
there are circulating folylpolyglutamates in serum (Cooper-
man and Luhby, 1965; Banerjee and Chatterjee, I966) but 
these findings are very likely due to hemolysis of the red 
cells. Others were unable to find intact circulating folyl­
polyglutamates and stated that the major folate compound 
of human (Herbert et al, 1962) and animal (Bird et al, 1965) 
serum is 5-methylTHF, which Is now generally assumed. The 
mean serum concentration in human varies from 5.1 - 15.9 
microgr/1., but the mean values are widely scattered for 
the several authors (Blakley, I969) depending on the assay 
methods and dietary conditions (Traill, 1969; Dawson and 
Geary, 1971)· The mean serum concentrations of many animals 
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is in the same range (Frank et al, 19^3) but ¡η the rat a 
significantly higher mean concentration (62 microgr/1.) is 
reported (Bird et al, 1965). Serum and plasma contain simi­
lar amounts of 5-methylTHF (Herbert, 1961) but the red blood 
cells contain 9 " 10 times as much folates, more than 90% 
in the gamma-glutamylpeptide form (Noronha and Aboobaker, 
І96З). About 61*% of the serumfolate is proteinbound (Traill, 
I969). 
The uptake of serum folate by tissues initially seems 
to be a folate binding on membrane-proteins. Johns et ai 
(1961), injecting various doses of tritiumlabelled folic 
acid intravenously, showed that 90 - 35% was removed in 3 
minutes (60% of it in one circulation time). Labelled un-
metabolized folic acid could be displaced from the cells by 
large 'flushing' doses of unlabel led folic acid at any time 
up to 3 days after the initial dose of tritiumlabelled fo­
lic acid, but the amount that could be displaced decreased 
with time. A similar pattern of rapid uptake and retention 
of antifolic drugs, like methotrexate, having a modified 
pteridine structure has also been showed (Johns et al, 196*»). 
Neal and Williams (I965) found that the rate of disappea­
rance from the serum is independent on the state of reduc­
tion of the used tritiated folates (folic acid, dihydro-
folic acid, tetrahydrofolic acid). 'Flushing' injections of 
folate or methotrexate were found to be just as effective 
in partly removing the retained folate. They suggest that 
the removal of folate from the blood is by means of a non­
specific binding onto 'cellular' proteins similar to the 
observed weak binding on serum proteins and not associated 
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with a specific uptake mechanism nor with folate utilizing 
enzymes. The retained folate varied between 25 and 50% of 
the injected doses, the remainder being unmetabolized and 
excreted in the urine. McLean and Chanarin (1966) observed 
that after intravenous injection of tritiated folic acid a 
rapid exchange occurred of this chemically prepared com­
pound with unlabel led tissue 5~methylTHF, which was ex­
creted in urine. Compounds lacking the pteridine moiety 
were unable to displace tritiated folic acid (Johns and 
Plenderleith, 1963), which is also showed for tritiated 
tetrahydrofolate intravenously (Chanarin and Perry, I969)· 
Henderson and Huennekens (197М observed an enhanced coun­
tertransport of 5~methy1THF from the intracellular space 
of the L.casei after addition of folic acid, di hydrofoil с 
acid, 5-formylTHF and amethopterin to the medium. 
The major site of folate metabolism and storage is the 
liver, containing about 7 mg (Baker et al, 196*0 of the to­
tal human body folates, 12 - 15 Щ (To-day's Drugs, 196Ό. 
About 85^ of the human liver folates consists of folyl-
polyglutamates containing more than 3 glutamyl residues 
(Whitehead, 1973), also seen in mammalian liver tissue 
(Whitehead, 1970; Shin et al, 1972) in which the predomi­
nant form is 5-methylTHF-pentaglutamate (Houlihan and Scott, 
1972; Shin et al, 1972; Corrocher et al, 1972; Thenen et 
al, І97З). Exogenous folic acid converts to this form (Hou­
lihan and Scott, 1972; Leslie and Baugh, 197*0. The endogenous 
folates are concentrated in the mitochondrial-lysosomal 
(21%) and cytoplasmic fractions (71%) and subsequent loca­
lization of radioactivity after metabolizing of injected 
з ^ 
tritîated folic acid indicates that conjugation nust occur 
in one or both of these sites (Corrocher and Hoffbrand, 1972), 
probably cytoplasm as the major site (Wang et al, 1967). 
Liver folate coenzyme content should not change significant-
ly during the whole day (Barbiroli et al, ^Э7^^). 
The universal occurrence of peptide derivatives of folic 
acid suggests that the polyglutamyl moiety must serve an 
important biologic role. Wright (1956) reported that serine-
hydroxymethylase of bacterial extracts performs its cataly­
tic role better with a fully reduced folylpolyglutamate than 
with the corresponding folylmonoglutamyl derivative. For in­
fection of the E.coli by the T-even bacteriophage the latter 
requires a folylpolyglutamate derivative, whereas deconju-
gation of a single glutamyl residue prevents infection of 
the host cell (Kozloff et al, 1970). The turnover rate of 
rat liver folates suggests that the pentaglutamates serve 
specific metabolic functions (Thenen et al, 1973). THF 
serves as substrate for the folylpolyglutamate synthesis 
in E.coli (Griffin and Brown, 196^), while Lavoie et al 
(197Ό made the concept also acceptable by proving that in 
human cells this is also the case. Vitamin B12 plays phy­
siologically an important role in this metabolic step. 
Noronha and Silverman (1962) and Herbert and Zalusky (1962) 
proposed the 'methyltrap' hypothesis including that vita­
min B12 deficiency causes an accumulation of 5-methylTHF 
at the expense of other folate derivatives, due to the de­
creased activity of the vitamin B12 requiring 5~methylTHF: 
homocysteine methyl transferase. The resulting depletion of 
THF increases the urinary excretion of formiminoglutamic 
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acid, commonly observed In either folate or vitamin B12 
deficiency. Also the folylpolyglutama tes are severely de-
pleted in erythrocytes (Jeejeeboy et al, 1965) and rat li-
ver (Kutzbach et al, 19^7)· Besides vitamin B12 also me-
thionine administration restores the depletion of folates 
(Kutzbach et al, 196?; Gawthorne and Stokstad, 1971; Thenen 
and Stokstad, 1973), but until now no satisfactory expla-
nation of the methionine effect has been given. Kutzbach 
and Stokstad (1967) found that in vitro the activity of 
5.10-methyleneTHFreductase, the enzyme responsible for for-
mation of 5~niethy1THFt is inhibited by SAM, a product of 
methionine metabolism. They suggested that the action of 
methionine in relieving the deficiency of folates was to 
Inhibit the formation of 5-methylTHF by this mode. Gaw-
thorne and Smith (197*0 however postulated that in vitamin 
B12 deficiency the folate metabolism of liver cells fails 
because of an impairment in the rate of transport of fo-
lates into the cells. Methionine should stimulate this 
transport directly and vitamin B12 may promote this action 
indirectly by increasing the activity of S-methyl-trans-
methylase thereby raising the intracellular concentration 
of methionine. Buehring et al (1972) observed that methio-
nine did not influence the uptake of folic acid into the 
perfused liver of rats fed on a vitamin B12 deficient diet. 
With folic acid in large unphysiological doses the folate 
disturbances in vitamin B12 deficiency should also be re-
stored (Lavo i e et al, 197*0 because they observed a normal 
folylpolyglutamate synthesis from administered folic acid, 
but not from administered 5"methylTHF, in vitamin B12 de-
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ficìent human cells. They also suggested that vitamin B12 is 
required In demethylat ion of 5~methylTHF rather than in 
folylpolyglutamate synthesis. Conversion of folates from 
monoglutamate into polyglutamate forms is probably necessary 
for retention in the cells (Brown et al, 197*0· Gutstein et 
al (І97З) reported that a patient with a combined folate 
and vitamin B12 deficiency due to tropical sprew did not 
respond to 5~methylTHF but to vitamin B12. 
Folylpolyglutamate synthesis seems to be a rapid process. 
Of a labelled dose folic acid injected intraperitoneally 
in rats, a steady state was reached in the liver within 2^ 
hours, and over 30% was of penta- and hexaglutamyl forms 
(Leslie and Baugh, 197*0· The rate of biosynthesis however 
is different for several animal species (Brown et al, 197*0· 
The cerebrospinal fluid folate level is approximately 
3 times higher than in serum (Herbert and Zalusky, 1962; 
Boykin and Hooshmand, 1970; Spaans, 1971). Only 5% is pro-
teinbound (Markkanen and Himanen, 1971) in contrast with 
the serum protein binding. The predominant form is 5~methyl-
THF (Wells and Casey, 1967; Alperin and Haggard, 1970), also 
the circulating folate derivative in serum. The uptake of 
this compound is an active transport process (Herbert and 
Zalusky, I962; Woodbury and Kemp, 1970) dependent on the 
serum folate level (Alperin and Haggard, 1970; Reynolds et 
al, I972). Levitt et al (1971) observed in dogs that there 
is a rapid CSF-uptake from serum for doubly labelled 5-methyl-
THF, which was also the only folate derivative identified in 
CSF after injections of labelled 5-methylTHF, 5-formylTHF 
and folic acid, indicating a conversion of folate derivati-
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ves (unlike 5-methylTHF) to 5"niethylTHF before uptake in 
the CSF. 
The total brain folate contents for mammalians seems to 
be approximately 0.2 ng/mg wet weight (Bridgers and McClain, 
1972; Obbens, 1973), far less than that found in liver 
(Gawthorne and Stokstad, 1971; Thenen and Stokstad, 1973). 
The proportion of the folylpolyglutamate forms seems to be 
about the half of the total brain folate, also much lower 
than in other tissues, while they found that about 50% of 
the mouse brain folates were methylated (Bridgers and Mc 
Clain, 1972). Subcellular distribution revealed that fo-
late was split approximately evenly between the crude cyto-
plasmic (soluble) and crude particulate fractions. The pu-
rified mitochondrial fraction contained only 5-methyl deri-
vatives, much of which was in the polyglutamate form. The 
non-cholinergic synaptosomes contained about 2 times more 
total folate than the cholinergic synaptosomes, while the 
fractions of methylated and polyglutamate forms were 
doubled in the former. The synaptosomal folate seemed to 
be largely bound to the synaptosomal membrane. In a later 
study(McClain et al »1975) the folate content of subcellu-
lar fractions of mouse brain however was not equal to the 
earlier findings of Bridgers and McClain (1972) despite 
the same techniques. Korevaar et al (1973) have measured 
the regional distribution of folates in brain of rats and 
found that the midbrain raphe and corpus striatum contained 
the highest level of 5-niethylTHF after conjugase treatment 
(O.I6 ng/mg wet weight and 0.23 ng/mg wet weight respecti-
vely), which are also the regions with the highest density 
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of 5-HT containing cell bodies (Palkovits et ai, 197*0 . 
In rats receiving a folate-deficient diet after weaning 
the brain folate content remained within the limits 0.^ 
to 1.05 ng/mg brain homogenate, but in rats weaned from 
folate-deficient mothers the brain folate activity fell 
to 65% of the mean normal value (0.63 ng/mg brain homo-
genate) (Allen and Klipstein, 1970). They did not mention 
the duration of the diet. DPH administration (duration 
was also not mentioned) produced no significant change 
in brain folate activity compared to a'control'group of 
rats receiving a folate-deficient diet. 
Processes, which can cause folate deficiency, are: 
- inadequate diet (e.g. in developing countries and alco-
hol ism) 
- insufficient absorption (e.g. tropical sprew, antiepilep-
tics?) 
- elevated need (e.g. pregnancy, increased cell turnover) 
- disturbances in folate metabolism (e.g. folic acid anta-
gonists, antiepileptics?) 
The FIGLU-test is an important tool in proving folate defi-
ciency (Luhby et al, 1959; Castaigne et al, I969)· 
Severe folate deficiency can lead to megaloblastic anemia, 
which is morphologically indistinguishable from that due to 
a vitamin B12 deficiency. Severe folate deficiency can also 
lead to neurological diseases like organic brain syndrome 
and pyramidal tract damage (Reynolds et al, 1973). neuro-
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psychiatric complications like dementia in epileptic pa-
tients (Reynolds et al, I967)· Low serum folate values 
have been reported in psychiatric patients taking anti-
psychotic drugs (Carney, 1967) and in women taking combi-
nation-type oral contraceptives (Majid Shojania, 1971). 
Arakawa et al (I967) reported an inborn error of folate 
metabolism associated with mental retardation, a marked 
dilatation of cerebral ventricles, massive myoclonic sei-
zures and megaloblastic anemia. In rats the syndrome of 
folate deficiency consists of weight-loss, diarrhoea, fai-
llng to maintain a normal rate of growth, chromodacryorrhoea 
('bloody tears': the loss of a red pigment through the tears 
thereby causing a reddish-brown incrustation, which appears 
first around the eyes and nostrils, subsequently on the 
front paws,then the fur of the head and back of the animal), 
an almost complete loss of hair, mucous ulcers of the tongue 
and/or oral cavity and finally blooddyscrasia (Darke and 
White, I95O). Chida et al (1972) found a desaturation and/or 
hydroxylation of long chain fatty acids in growing rats due 
to dietary folate deficiency. Brandriss (i960) suppressed 
the experimental allergic encephalomyelitis with amethopterin 
( a folate antagonist). 
?9l§Í§_§ÍÍJSl2ÍÍESÍ§ 
Folate in high dietary doses could lead to gastrointesti-
nal disturbances, mental changes and sleep disturbances in 
humans (Hunter et al, 1970) and in mice to initial loss of 
weight and severe renal tubular damage (Searle and Blair,1973). 
i»0 
Blair (I97O) suggested that the side-effects of large doses 
of folic acid are due to an inhibition of the enzyme DHF-
reductase in a manner similar to, but weaker than folate 
analogues in clinical use. The results of Hunter et al (1970) 
however were not confirmed by Gibberd et al (1970),Ralston 
et al (I970)and Hellström (1971). 
For extensive information about the biochemistry of fo-
lates, the reader is referred to Blakley (I969) and Bertino 
(I971). 
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C H A P T E R 5 
RELATIONSHIPS BETWEEN FOLATES. DIPHENYLHYDANTOIN AND EPILEPSY 
Anticonvulsive medication, especially ΟΡΗ, phénobarbital, 
primidone or a combination of these drugs, can disturb the 
folate metabolism in humans and animals, resulting frequent-
ly in subnormal folate levels of serum and CSF, macrocytosis 
and neuropsychiatrie disorders (reviewed by Reynolds, 1972). 
Megaloblastic anemia however is rarely found (about i% of 
the treated epileptic patients is suffering from it). The 
mechanism of these drug-induced folate disturbances has yet 
to be determined. Several attractive theories have been pro-
posed, but also disputed by others (referenced by Waxman et 
al , 1970; Reynolds, 1972): 
- inhibitory effect of the anticonvulsants on gamma-carboxy-
peptidase in the gut lumen 
- malabsorption of free folic acid from the small intestine 
(drug-induced Intraluminal pH changes are suggested) 
- displacement of folate from its plasma carrier protein 
- structural resemblance of the pyrimidine rings of phéno-
barbital and primidone to that of folic acid and the 5" 
ring structure of the diphenylhydantoin molecule to the 
5.10-methylene ring structure of 5·10-methyleneTHF, re-
sulting in competitive inhibition by these anticonvul-
sants in the folate metabolism or folate-mediated systems 
- increased induction of liver hydroxylating enzymes which 
require folates for functioning 
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- impairment of folate transport into various tissues 
Recently the following theories have been added: 
- Maxwell et al (1972) suggested a hepatic enzyme induction 
by anticonvulsants resulting in an increased DNA and 
RNA synthesis, associated with increased folate needs. 
- Arakawa et al (1973) observed a DPH-induced elevation of 
the 5"niethylTHF — homocysteine transmethylase activity, 
resulting in decreased serum 5"methylTHF. 
- Corrocher et al (197Ό proposed a competition between fo­
lates and anticonvulsants for the binding on 'Y' and 'Z' 
hepatic proteins, which may be involved in the transfer 
of folate from plasma to liver. 
It has been postulated that the antifolate effects of anti­
convulsants may be related to their therapeutic action 
(Reynolds, 1967). To correct these drug-induced folate dis­
turbances folic acid is administered, mostly orally in a do­
se of 5 - 15 mg. In I960 Chanarin noted firstly that folic 
acid administration to an epileptic patient exacerbated his 
epilepsy. This remarkable finding was confirmed later by 
others, but also ignored (see Reynolds, 1972). Till now 
there are still conflicting views of the effects of folic 
add treatment, also on DPH metabolism. Viukari (I968) 
suggested that an increased biotransformation of DPH, re­
sulting in a fall of its serum level, caused the folate-
induced increased fit frequency. Kutt et al (I966) reported 
an increased parahydroxy lat Ion of DPM during folic acid 
treatment in a patient, intoxicated by DPH. Olesen and Jen-
Ό 
sen (1970) and Baylis et al (1971) observed a decrease in 
serum DPH after folic acid treatment. Serum and CSF levels 
of phénobarbital and DPH were significantly lower in folic 
acid treated epileptic patients (Mattson et al, 1973). In 
spite of marked elevation of folate in serum, there was no 
apparent entry into the CSF in contrast with patients re-
ceiving 5-formylTHF. They assumed that anticonvulsants in-
terfere extraneurally with the conversion of folic acid to 
S-methylTHF, which was also postulated by Levitt et al 
(I971), Lacy and Smith (1973) and Smith and Farnham (1971»). 
DPH in contrast to chronic ethanol feeding did not seem to 
impair the folylpolyglutamate synthesis in rat liver cells, 
from a tracer dose of tritiated folic acid (Brown et al, 
І97З)» but their used DPH dose and pretreatment is question­
able. No influence of folic acid on the DPH status was seen 
by Spaans (1971) and Andreasen et al (1971). In experimental 
studies of Woodbury and Kemp (1971), de Wolff et al (1971), 
Smith and Racusen (1973), Lacy and Smith (1973) and Smith 
and Farnham (197iO the anticonvulsant efficacy of DPH or 
phénobarbital was reversed by folates. Thus very likely 
there exists a mutual influence of folates and anticonvul-
sants on each other. Smith and Farnham (197'*) suggested that 
5-methylTHF may be the most important metabolite involved 
in the interaction between anticonvulsants and folate meta-
boi ism. 
Folic acid itself or its derivatives have striking con-
vulsant properties (Hayashi, 1959; Noel 1 et al, I960; Hom-
mes and Obbens, 1972; Baxter et al, 197'»; Smith and Farnham, 
I97'*) or excitatory effects on other excitable tissues 
w 
(Spector, 1972a; Jenkins and Spector, 1973). Mayersdorf et 
al (I97I) reported changed levels of folylpolyglutamate in 
foci rendered epileptic by cobaltpowder: an elevated tissue 
level was reported both at the primary and the mirror focus 
in one chronic monkey experiment (8 months), whereas in acu-
te cat experiments ( 1 - 8 weeks) there was an elevated level 
at the mirror focus but a decreased level of folylpolygluta-
mates at the primary (folyImonoglutamate levels at the pri-
mary focus were normal). No further differentiation in me-
thylated and non-methylated derivatives was made nor amounts 
of the brain folate levels were given. 
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C H A P T E R 6 
FOLATE DERIVATIVES AND EXPERIMENTAL EPILEPSY 
Because this present work has been performed In the same 
laboratory as the study of Dr. E.A.M.T. Obbens, a short sum-
mary of previous experimental results is as follows (Hommes 
and Obbens, 1972; Hommes et al, 1973; Obbens and Hommes, 
1973; Hommes and Obbens, 1973; Obbens, 1973): 
High intravenous doses of the sodium salt of folic acid (Na-
folate, ^5 - 125 nig) caused tonic-clonic or clonic seizures 
in normal rats, but when the blood-brain barrier is damaged 
by a heat lesion of the cortex cerebri low intravenous doses 
of Na-folate (15 mg) evoked epileptic reactions consisting 
of focal discharges In the EEG with visible contralateral 
jerks as well as focal seizures, often secondary generalizing 
which are also clinically visible. Radioautography showed 
that Na-folate or a folate derivative, intravenously injected, 
penetrated at the site of the heat lesion within 15 minutes. 
In rats rendered epileptic by cobaltrod implantation into 
the cortex cerebri on the same locus as heat lesions were 
made, 5 - 10 mg Na-folate intravenously enhanced strongly 
the coba 11-induced epilepsy In the EEG as well as clinically 
(later confirmed by Chatta et al, 197^), whereas a folate-
deficient diet during 2 months did not reduce the amount of 
the coba 11-Induced contralateral jerks. 
When the blood-brain barrier was circumvented by intra-
cortical or intrac¡sternal injections, already very low doses 
of Na-folate (2.4 microgr intracortically and 0.05 mg Intra-
kb 
cisternally) produced strong epileptogenic activities, also 
in cobalt epileptic rats. A difference in epileptic activi-
ty between Na-folate and K-folate intracortically could not 
be demonstrated. 
Some tested folate derivatives showed the same properties 
as Na-folate, but in this respect 5-formylTHF had the strong-
est epileptogenic action. Some parts of the folic acid mole-
cule (pterin, paraaminobenzoic acid, GA) did not produce 
epilepsy. 5~MethylTHF was not tested. 
Pretreatment with pyrimethamine intracortically, a folate 
antagonist that inhibits dihydrofolate-reductase, inhibited 
the epileptogenic action of Na-folate intravenously in rats 
with a cortical heat lesion. Methotrexate, also an inhibi-
tor of this enzyme, did not show any effect on Na-folate 
epilepsy. 
Hepatectomy (partial) or a ligature of the portal vein 
reduced the epileptogenic activity of 125 mg Na-folate intra-
venously in normal rats up to 100%. 
Of the tested anticonvulsants DPH and valium only the lat-
ter produced in very high doses (2.5 - 17.5 mg/kg body weight) 
a disappearance of the jerks and a decrease in epileptic dis-
charges in the EEG. 
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C H A P T E R 7 
PROBLEMS 
The above mentioned findings indicate an important, but 
far from obvious role of folates in clinical and experimen-
tal epilepsy. Many questions remain to be resolved. 
The problems, which led to this experimental study, were: 
- does folate deficiency afford protection against epilep-
tic phenomena? 
- what are the consequences of influencing the folate meta-
bolism in folate-induced epilepsy? 
The first problem was approached mainly by means of diet ex-
periments, while the second one was approached by experi-
ments with DPH, SAM, partial hepatectomy and folate-anta-
gonists. 
Later, results of DPH in focal folate epilepsy evoked a 
third problem: 
- what influence has folate on DPH kinetics? 
48 
C H A P T E R 8 
METHODS AND MATERIALS 
1. An2nia]s_and_djets 
The animals used in this study were adult female Cpb:WU 
rats in SPF (specific pathogen free) condition. In the acute 
experiments, the bodyweights of the animals ranged from 
160 - 180 gr. , in the chronic diet-experiments initially from 
160 - 190 gr. The diets on which the rats were fed in this 
study varied. One group was fed on a standard diet (table 2) 
and the other groups were fed on one of the two special 
diets which are given as follows: 
I. according to the standard diet except that the folate 
content was changed: 
a. a folate-deficient diet containing O.** mg folate/kg 
b. a folic acid supplemented diet containing 500 mg 
folic ас id/kg 
c. a folic acid supplemented diet containing 50 gr 
folic acid/kg 
II. a vitamin B12 and methionine deficient diet according 
to that used by Thenen and Stokstad (1973). The folic 
acid content of this diet was 5 mg/kg. 
All the diets were prepared by Hope Farms (Woerden, The 
Netherlands). The rats fed on the folate-deficient diet re­
ceived sulphathiazole in their drinking water at a concen­
tration of 3 gr/l to achieve an inhibition of the folic acid 
synthesizing intestinal microflora. The rats were housed in 
Ί9 
stainless steel cages with a wire bottom (maximal 5 rats 
per cage), placed in an animal room with a temperature of 
220C and a humidity of about 50%. 
Protein total t 22Λ Trace elements 
otein-digest¡ble 'I 
Arginine % 
Lysine * 
Methionine % 
Cystine t 
Tryptophan t 
Fenylalanlne % 
Tyrosine X 
Leucine % 
Isoleucine t 
Histidine % 
Threonine X 
Valine I 
It % 
Llnoleic acid X 
ber t 
nera Is X 
Calcium X 
Phosphorus X 
Potass i ія> % 
Magnesium % 
Sodium % 
21.3 
1.20 
1. li. 
0.52 
0.28 
0.2Î 
1.00 
0.71 
1.52 
0.98 
0.53 
0.75 
1.16 
6.5 
2.3 
<..2 
S.i. 
1.03 
0.78 
0.59 
0.28 
Ο.Ί* 
Iron mg/kg 
Manganese mg/kg 
Zinc mg/kg 
Copper mg/kg 
Cobalt mg/kg 
Iodine mg/kg 
Vitamin A iu/kg 
Vitamin D3 iu/kg 
alpha-Tocopherol (E) mg/kg 
Vitamin К mg/kg 
Thiamin (Bl) mg/kg 
Riboflavin (82) mg/kg 
Niacin mg/kg total 
Niacin mg/kg available 
Panthotenic acid mg/kg 
Fol le acid mg/kg 
Pyridoxine (66) mg/kg 
Chol ine mg/kg 
Vitamin B12 meg/kg 
Biotin (Η) meg/kg 
Vitamin С mg/kg 
137.О 
60.8 
37.0 
21.2 
0.12 
0.52 
22800.0 
3700.0 
88.5 
5-2 
lt.8 
10.5 
72.1 
29.I 
23.3 
2.7 
8.7 
1538.0 
31.0 
+ 200.0 
100.0 
Table? Standard diet. 
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In the experiments concerning the influence of the vari-
ous diets on generalized epileptogenic phenomena,2 chemicals 
with a strong epileptogenic action were used: 
® 
- Megimide (bemegride) was injected intravenously in doses 
of 7 mg/kg body weight to evoke generalized tonic-clonic 
or clonic seizures. The purpose of this method was to 
measure possible influences of the various diets on the 
seizure duration. Information about distribution of megi-
mide in animal tissues after intravenous injection is gi-
ven by Graham and Nichols (1959)· The duration of the sei-
zures was measured by observation in time. 
- Pentetrazole (Cardiazole1? Leptazole, Metrazole)® of which 
the fate in the rat body has been studied by Esplín and 
Woodbury (I956), was pumped intraperitoneally in the rat 
body with a constant rate of 1 ml/20 min. and a concen-
tration of 10 mg/ml during EEG-recording. With this mode 
of action it was possible to determine precisely the ap-
pearance of the first paroxysmal bilateral synchronic 
discharges (fig. 1) and the beginning of a generalized 
clonic seizure. The first and second threshold were cal-
culated from the administered dose pentetrazole/kg body 
weight for the first paroxysmal bilateral synchronic 
discharges and the generalized clonic seizure respecti-
vely. For the determination of these threshold levels 
the rats were fixed in a stereotaxic frame and a set of 
electrodes were connected to the bone structure of the 
skull. Bipolar recordings were made on an 8-channel 
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Fig.l Paroxymal bilateral synchronie discharges. 
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Fig. 2 Focal discharges from a fol ate-activated cortical heat lesion. 
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Elema Mîngograph (see Ногте« and Ohhpn«;. 1472). 
In the acute experîments сопсггп:пд the influence of chemi­
cals on folate-induced epilepsy a heat lesion was made: 
under aether-anaesthesia the bare skuH was heated over the 
right sensorimotor area with a sliver plate of 2 mm diame­
ter, a temperature of 80 С and a duration of 1 minute, ac­
cording to the technique of Hommes et ai (1973)· After Ь 
hours the EEG was recorded and the heat lesion was activa­
ted by intravenously injected fol te acid to evoke the fo­
cal discharges (fig. 2). With an increasing time duration 
one can observe repeatedly both foca* (unilateral) and 
secondary generalized Ibi latera1) seîyjres (fig. 3). When 
a generalized folate-inducad seizure was not preceded by 
focal discharges it was called a primary generalized sei-
zure. No distinction was marie Ьеіі еел focal or secondary 
generalized seizures in the ca'cuïetions. The duration in 
seconds of such a seizure is called seizure activity. For 
extensive information about experimental models of epilepsy, 
the reader is referred to Purpura et ai (1972). 
Fig. 3 Secondary generalized seizure from a cortical folate-adivated heat lesion. 
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For folic acid Injections a stock solution of folic acid 
sodium salt USP, not older than 1 month, was used with a pH 
of 7-4. When It was necessary, such a solution was diluted 
with destilled water. 
For experiments concerning chronic administration of DPH, 
stock solutions of DPH sodium salt with pH 11 in destilled 
water were made. In one study Epanutinu(Parke-DavlsJ, DPH 
sodium salt BP in a solvent containing k0% propylene glycol 
and 10% alcohol In water, was used. 
Solutions of the other tested chemicals were freshly made 
or directly given from the ampullae. 
A ta 11 vein of the rat was used for intravenous (i.v.) 
injections and the intracortical (i.cort.) injections were 
given in the same local area as the heat lesions, at a 
depth of 1 mm from the cortical surface. A minimal volume 
of 0.0002 ml was injected with a micro-injector (Agla) 
after first fixing the rat in the stereotaxic frame, tre-
pantng the skull, and under EEG-recordlng of the unan-
aesthetlzed rats. Intracisternal (¡.cist.) Injections of 
0.001 ml were given with a micro-Injector (Hamilton) In 
the cerebro-medullar cistern. 
5*· 
Ц. The_mjçrobjo2ogjçal_assay_gf_folates_2n^bra2n_and_serum/ 
Pli§!I,5_9f_î!3Ç_E2îi 
P R I N C I P L E S (See Blakley, I969 and Bertino, 1971) 
The levels of folates were determined with Lactobacillus 
casei (ATCC 7H9) and Streptococcus faecal is (ATCC 80^3) as 
test organisms. These organisms are unable to utilize the 
naturally occurring higher poly-gamma-glutamyl forms of fo-
lic acid. L.casei is active for all folates containing three 
or less glutamyl moieties, whereas S.faecal is responds to 
folates containing one or two glutamyl moieties with the ex-
ception of the methylated forms. The difference in activity 
of these two test organisms Is a measure for the 5-methyl-
tetrahydrofolate (S-methylTHF) level. Total folate levels 
were obtained after prior treatment of brain extracts with 
chicken pancreas conjugase. This specific gamma-carboxypep-
tidase breaks down polyglutamate derivatives of folic acid 
to the corresponding mono- or diglutamyl folates. The brain 
extraction procedure for folates was made by pH 7.8, the op-
timum condition of the chicken pancreas conjugase. 
M A T E R I A L S A N D M E T H O D S 
Reagents and glassware 
Chemicals of analytic reagent grade were used. Solutions 
were made up with glass-destl1 led water. Glassware was clean-
ed by soaking overnight in 'Extran flüssig' and was rinsed 
8 times In hot tap water and 6 times In de-Ionized water. 
Aluminium caps were washed In hot tap water and de-ionized 
water. 
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Lactobacilli broth AOAC and special agar-noble: Difco Lab. 
Dano Folic acid easel medium (dehydrated): Wi11-Pharma,A'dam. 
Pteroylglutamlc acid and ascorbic acid: Sigma Chemical Cie. 
Extran flussig, NaCI, КН^О^ anhydrous and Na^HPO^· ZhLOrMerck. 
Phosphate buffers 
Solution A : 9.08 gr KH.PCK (anhydrous) dissolved in desti 1-
led water and made up to 1 I solution in a volumetric flask. 
Solution В : 11.87 gr Na2HPOi|· 2H20 dissolved in desti lied 
water and made up to 1 1 solution in a volumetric flask. 
Phosphate buffer pH 6.1 
85.О ml Solution A was mixed with 15.0 ml solution B. Even­
tually the pH had to be corrected. This buffer was then 
autoclaved at 120OC for 30 min. Immediately before use 
100 mg ascorbic acid was added to 100 ml of the buffer. 
Phosphate buffer pH 7.8 
8.6 ml Solution A was mixed with 91.4 ml solution B. Even­
tually the pH had to be corrected..Immedlately before use 
100 mg ascorbic acid was added to 100 ml of the buffer. 
Preparation of standard solutions 
20.0 mg Pteroylglutamlc acid, 2 ml 0.1 N NaOH and 10 ml 
destllled water were mixed together. The pH was then cor-
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rected to 7·0 with 0.1 Ν HCl and the solution was made up to 
100 ml in a volumetric flask with destilled water. This stock 
solution was stored In glass vials at - 20 C. The working so­
lution, containing 0.2 ng pteroylglutamic acid per ml, was made 
by diluting the stock solution with phosphate buffer pH 6.1 
Immediately before use. 
Preparation of serum/plasma samples 
The serum/plasma, not directly used for assay, was immedia­
tely stored at - 80OC. 
Serum/plasma dilutions were made up with phosphate buffer 
pH 6.1 (vide infra) and then autoclaved for 5 min. at 118 C. 
The coagulated proteins were removed by centrifuging twice 
at 3000 r.p.m. for 15 min. The clear supernatant was immedia­
tely used for assay. The following serum/plasma dilations 
were made: 
Rats fed on a diet: Fol ate/kg diet L.casei S.faecal is 
O.k mg 
2.7 mg 
500 mg 
50 gr 
Preparation of brain extracts 
80 
180 
600 
2000 
50 
100 
'tOO 
1750 
Directly after excision brains were washed with 0.9% NaCI 
and rapidly frozen at - 80 C. A complete frozen brain was min­
ced in a mortar, cooled with liquid N-. The frozen powder was 
# 
This assay of brain folates has been developed in the Labo­
ratory of Neurology. 
57 
then transferred to a cooled glass vial and mixed with 8.0 ml 
phosphate buffer pH 7.8. Immediately thereafter the suspension 
was heated in a boiling waterbath for exactly 2 min. to des­
troy the endogenous conjugase and then cooled in an Ice-water-
bath. The suspension was centrifuged for 15 min. at 3000 r.p.m. 
The supernatant fluid was transferred to a 25 ml volumetric 
flask. The sediment was washed with 5.0 ml phosphate buffer 
pH 7.8 and after centrifuging again the supernatant was trans­
ferred to the same 25 nil volumetric flask. The volume of this 
extract was made up to 25 ml with phosphate buffer pH 7.8. The 
clear extracts were then stored at - 20 С in small test tubes 
until assay. Just before measuring the brain extracts were di­
luted with sufficient phosphate buffer pH 6.1 and then auto-
claved for 5 min. at 118 C. The coagulated proteins were remov­
ed by centrifuging twice at 3000 r.p.m. for 15 min. The clear 
supernatant was Immediately used for assay. 
Conjugase preparation 
10 gr Fresh chicken pancreas was defatted and homogenized 
in 200 ml phosphate buffer pH 7.8 in a Waring Blendor. The 
suspension was centrifuged and incubated In a waterbath at 
32 С for 16 hours and thereafter centrifuged for 15 min. at 
3000 r.p.m. The supernatant fluid was dialysed at Ί С against 
phosphate buffer pH 7.8 for 20 hours. The dialysed liquid was 
centrifuged for 15 min. at 3000 r.p.m. and frozen at - 20 С 
for 6 hours. The procedure of incubation, dialysing, freezing 
and centrifugation with the dialysed fluid was repeated until 
the endogenous folates were almost completely removed. The 
clear enzyme preparation was stored at - 20 С in small test 
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tubes until use. Purified chicken pancreas conjugase has a 
pH optimum at 7-8 and a temperature optimum at 32 С 
Conjugase treatment of brain 
The extracts were incubated with conjugase in closed glass 
vials in a waterbath at 32 С for 16 hours. The incubation mix­
ture had a total volume of 2.0 ml which is composed of 0.5 mí 
conjugase and 1.5 ml of brain extracts and phosphate buffer 
pH 7.8. After incubation, phosphate buffer pH 6.1 was added. 
The samples were autoclaved for 5 min. to inactivate the con-
jugase. The denaturated proteins were removed by centrifugation 
at 3000 r.p.m. for 15 min. The clear supernatant was directly 
assayed for total folate levels. Corrections were made for the 
remaining folates in the conjugase preparation. 
Maintenance of assay microorganisms 
L.casei and S.faecal is were maintained as stab culture 
in Lactobacilli broth AOAC with 1% agar and subcultured 
monthly. The medium was prepared according to manifactu-
rer's instructions. The cultures were stored at k C. 
Preparation of the inoculum 
This procedure was similar for L.casei and S.faecal is. 
A test tube with 10.0 ml Lactobacilli broth AOAC was 
Inoculated from the stock culture with an inoculating 
needle and incubated in a waterbath at 37 С for 16 
hours. 
The Inoculated culture was equally divided Into 
two sterile centrifuge glass tubes with aluminium caps. The 
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tubes were centrifugea for 10 min. at 3000 r.p.m. and the 
supernatant liquid decanted. The cells were washed k times 
with 5 ml O.S% sterile NaCl solution and centrifuged. Then 
the cells from one of the tubes were suspended in 10 ml 
sterile 0.3% NaCl solution and from this suspension 0.5 
ml was resuspended in 10 ml sterile 0.3% NaCl solution. The 
latter was used for Inoculation of the assay medium. 
Assay medium 
Dano dehydrated folic acid casei medium was used for the 
assays with L.easel and S.faecal is. Double-strength medium 
was prepared according to mani facturer's instructions, how­
ever without autoclaving. The medium is stable for 1 week 
If stored at - 20oC. 
Immediately before use 0Л ml diluted cell-saline suspension 
was added to 100 ml of the medium. The solution was thorough­
ly mixed with a magnetic stirrer. 
The assay 
This procedure was similar for L.casei and S.faecal is. 
Standard folic acid solutions were set up quadruplIcately 
for the standard curve as shown In table 3· 
Table k illustrates the assay procedure for the determina­
tion of folate activity in serum/plasma/ brain samples 
which were performed triplIcately. 
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Table 3 
Tube number Blank Blank 
Fol ic acid solution 0.2 ng/ml - - 0.5 1.0 1.5 2.0 2.5 ml 
Phosphate buffer pH 6.1 2.5 2.5 2.0 1.5 1.0 0.5 
Assay med Iurn,not Inoculated 2.5 
Assay medium. Inoculated - 2.5 2.5 2.5 2.5 2.5 2.5 
Table Ί 
Tube number 
Sample 
Phosphate buffer pH 6.1 
Assay medium, Inoculated 
0.5 
2.0 
2.5 
1.0 
1.5 
2.5 
1.5 
1.0 
2.5 
2.0 
0.5 
2.5 
ml 
The test tubes were closed with aluminium caps. After mixing 
on a Vortex mixer the test tubes were Incubated for 17 ~ 20 
hours at 370C In a waterbath. The growth of the standards 
and samples were measured In a Vitatron spectrophotometer, 
fitted with a flow cell (filter 6lA nm). The turbidity mea­
sured as % of transmission Is a measure for the folate acti­
vity. 
Calculations 
Calculations were made with a semilogarithmic regression pro­
gramme using the Hewlett-Packard 98IO A calculator. 
The variation-coefficient of the determination is 8%. 
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5· 2ÊÎÇr!PiD§îi9D-9f_ÎiBÎÎSDïibï^âDÎSlO 
0.5 ml Plasma of rat blood samples was acidified with 
100 micro) 1 N HCl and extracted with 5.0 ml chloroform 
containing 2 mg/l Toluyl - Phenyl - Hydantoln (TPH) as in-
ternal standard during 1 min In a glass stoppered tube on 
a Vortex mixer. k.Q ml Of the organic layer was transferred 
to another tube and evaporated to dryness. 
From the rat tissue samples approximately 1 gr was weighed 
and homogenized with 10 ml 0.3% NaCI. 1.0 ml Of the samples 
was acidified and extracted in a glass stoppered tube with 
chloroform (10.0 ml) containing the Internal standard TPH. 
9.0 ml Of the chloroform layer was transferred to another 
tube and evaporated to dryness. 
The residues were used for gaschromatographic analysis as 
described earlier by Cuelen and Vree (1975) using an alkali 
flame Ionisation detector. 
6. Graphjcs 
In the graphical representation of time scores the values 
have been rounded off to 1/4 min. Mean values are represented 
by « — * . 
The Wllcoxon's two sample test, Wilcoxon's paired test 
and Spearman's rank correlation test were used. The criterion 
of significance was chosen at 2 alpha - 0.1. 
62 
C H A P T E R 9 
1. INFLUENCE OF CHANGED DIETARY FOLATE LEVELS ON MEGIMIDE-
INDUCED SEIZURES (exp. 1178) 
During a dietary folate-wlthdrawal (2 months) Obbens 
(1973) could hot demonstrate an influence of the diet on 
cobalt-induced focal epilepsy, clinically scoring the a-
mount of the hind-limb jerks, compared to cobalt-implanted 
controls on a standard diet. Schreiber and Zemp (1973) ob-
served that weanling mice from mothers on a folate-defi-
clent diet showed an increased incidence and severity of 
audiogenic seizures from the 22 - 36 day, compared to 
those from mothers on a folic acid supplemented diet (die-
tary folate contents were not mentioned). Smith and Racusen 
(1973) studied in rats the effects of dietary folate-with-
drawal and folic acid supplementation (5 times more than 
normal; amounts were not mentioned) on the anticonvulsant 
efficacy of phénobarbital in relation to the appearance of 
the first myoclonic jerk (first threshold) and to the be-
ginning of a full tonlc-clonic seizure (second threshold). 
This experimental generalized epilepsy was evoked by inha-
lation of the convulsant fluothyl. Rats,treated with phéno-
barbital, showed a very strong elevation of the second 
threshold when fed on a folate-deficient diet during 10 
weeks,compared to phenobarbltal-treated rats on a normal 
diet. On the contrary, the second threshold decreased 
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strongly in rats.treated with phénobarbital and fed on a 
diet supplemented with folic acid. The first threshold was 
not affected, therefore they suggested that the two thres-
holds are different qualities. Ho influence on both thres-
holds could be observed in untreated rats under different 
dietary folate circumstances. Phénobarbital levels were si-
milar in all treated groups, but the plasma folate levels 
were lowered In the anticonvulsant-treated rats; relative-
ly more In the rats on the folic acid supplemented diet. 
Lacy and Smith (1973) observed that folic acid i.p. (12 mg/ 
kg/day) had no apparent effect on the fIuothyl-induced 
seizure threshold and did not alter the anticonvulsant effi-
cacy of phénobarbital. However 5~formylTHF (12 mg/kg/day) 
reduced the anticonvulsant efficacy of phénobarbital with-
out affecting plasma phénobarbital levels, but it had no 
effect on seizure threshold in control animals not recei-
ving phénobarbital. Smith and Farnham (197Ό demonstrated 
that 5-methylTHF I.p. reduced the efficacy of phénobarbi-
tal in the f1uothyl-induced seizure threshold to a greater 
extent thant 5-formylTHF i.p. and folic add i.p., while 
5-methylTHF had an independent epileptogenic effect. Brain 
folate levels were higher In those animals receiving 5~ 
methylTHF whereas plasma folate and phénobarbital levels 
were constant between the groups. In threshold electroshock 
studies (Baxter et al, 197*0 the incidence of hind-limb 
extension was significantly increased by subconvulsive doses 
of folic acid intraventricularly or intravenously, while 
folic acid intraventricularly precipitated audiogenic sei-
zures. In the report of Spector (1972a) it is mentioned 
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that Carlisle and Spector (1971) observed no alteration of 
leptazol-induced seizure threshold in rats and mice after 
previously receiving orally or I.p. folic acid or 5-formylTHF, 
but the data here mentioned can not be found there. Woodbury 
and Kemp (1970) reported that the anticonvulsant effect of 
chronically administered DPH on maximal electroshock seizure 
pattern in mice Is counteracted by folic acid. 
Because of these contradictory reports about the effects 
of folate-withdrawal and folic add supplementation on epi-
leptic manifestations with or without anticonvulsive medica-
tion the following experiments were set up to study the ef-
fects of only dietary changed folate contents on epileptic 
manifestations. 
ÎÎÊÎÎÎ9S!§_§0iL!P3ÎSrl3.1§ 
Three groups, each consisting of 15 rats, were formed: 
one group on a folate-deficient diet containing Q.k mg fo-
late/kg; one group on a standard diet containing 2.7 mg 
folate/kg; and the other group on a folic acid supplemented 
diet containing 500 mg folate/kg. Besides this only the ani-
mals on the folate-deficient diet received sulphathiazole 
In their drinking water in a concentration of 3 gr/1 to pre-
vent folic add uptake by means of coprophagy. After 1 month 
a generalized seizure was evoked by injecting megimide i.v. 
In a dose of 7 mg/kg body weight in each animal. The total 
duration and nature (tonic-clonic or clonic) of each sei-
zure was measured by observation.This procedure was repeated 
each month for 1 year with the exception of the last (sel-
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Fig. 4 The megimide-seizure durations of the surviving rats during one year 
of diet (exp.1178) 
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Fig. 5 The habituation which occurs after repeatedly evoking of megimide-
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and to megimide-seizures of controls from other experiments. 
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zure 12) ¡η which the dose of megimide was changed. 
Results 
During the trial period several animals died. At the end 
of 12 months the control, folate-deficient and folic acid 
supplemented group contained 8, 9 and 13 animals respective­
ly. In flg. k the duration of all the seizures of each sur­
viving animal within the different groups in the 1 year 
trial period is separately represented. Because the tonic-
clonic seizures last longer than the clonic seizures the 
curves are blmodal. The points on the X-axis represent zero-
values, which means that the rats showed no epileptic reac­
tion at all after a megimide-injection. From 100% of all 
control rats 82.5% had tonic-clonlc seizures, the remainder 
having clonic seizures or no epileptic manifestation at all. 
In the folate-deficient group the percentage tonic-clonic 
seizures decreased to 64 and in the folic acid supplemented 
group to y'i.S. In fig. 5 one can observe the habituation 
which occurs after repeatedly evoking of megimide seizures 
within the control group. 
* 
A profile analysis of the course of the mean seizure du­
ration (seizure 7 ~ H ) in the folate-def icient and control 
group slightly indicates a protective action of a folate-
deflclent diet. Furthermore a significant difference was 
* 
Profile analysis was performed by the Department of Sta­
tistical Consultation (report 71*060). 
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found ín the mean seizure duration between the folate-defi-
cient and control animals during 1 year (Student t-test 
ρ » 0.05, seizure 2 - 11). Fig. 6 represents the cumulative 
seizure duration of the three groups. 
CUMULATIVE 
SEIZURE DURATION 
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Fig. 6 Cumulative seizure duration calculated at the mean seizure duration per 
group, (exp.1178). 
Because of Increasing differences In body weight between 
the folate-defIcient and the two other groups (fig. 7) the 
dose of megimide at the last seizure was changed: all ani­
mals received a dose which was calculated at the mean body 
weight of the control group. Thus the folate-deficient 
group was overloaded with the convulsant drug. The results 
are represented in fig. 8. Besides a significant difference 
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Fig. The mean body-weight per group during one year of diet (exp. 1178). 
Each point represents the mean value of body-weights of all rats in one group 
at that moment 
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The dose of megimide ( 7 mg/kg body weight ) was calculated at the mean body weight. 
(250gr.) of the control group. I exp. 1178). 
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Fig. 9 Relation between megimide-induced seizure duration and plasma/serum 
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between the folate-def¡cient and folic acid supplemented 
group (Wtlcoxon's two sample test 0.02>p>0.01), no other 
statistical differences were found. It has to be noted 
that the folate-deficient group was treated between sei-
zure 1 and 2 with meg im i de i.p. and the folic acid supple-
mented group not. 
Plasma samples (of heparinized blood) were collected 
after seizure 9 while serum samples were collected after 
seizure 12. It appeared that at both points of time a 
significant positive correlation was found between the 
height of the plasma/serum L.casei activity and the dura-
tion of the seizure (control + folate-deficient + folic 
acid supplemented group, Spearman's rank correlation 
0.01>p>0.001 and 0.05>p>0.02 respectively). The data 
are summarized in table 5 and schematically represented 
in fig. 9· Significant positive correlations were also 
demonstrated at both points of time between seizure dura-
tion and S.faecal is activity (0.01>p>0.00l both) as well 
as L.casei minus S.faecal is activity (0.01>p>0 .001 and 
0.05>p>0.02 respectively). 
After the last seizure the rats were killed under aether-
anaesthesia. Brain folate levels are summarized in table 5· 
From this summary (control + folate-deficient + folIc acid 
supplemented) we demonstrated the following correlations 
(Spearman's rank correlation): 
folylmonoglutamates seizure duration (seizure 12) 
L.casei activity: positive correlation 0.1>p>0.05 
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L.casei minus S.faecalis act.: positive correlation 0.1>p>0.05 
No correlation could be demonstrated between the S.faecalis 
activity and seizure duration. 
Also this means a significant positive correlation between 
seizure duration and brain 5-methylTHF level (fig. 10). 
folylpolyglutamates seizure duration (seizure 12) 
No correlations. 
fol γ 1 monoglutamates folylpolyglutamates 
L.casei activity: negative correlation 0.01>p>0.001 
L.casei minus S.faecalis activity: negative correlation 
0.01>p>0.001 
Again no correlation could be demonstrated with S.faecalis 
activity alone. 
This means a negative correlation between the methylated 
forms of folylmono- and folylpolyglutamates. 
Table 6 represents the mean values of the brain folates. 
Compared to the control group a slight indication in the 
folate-deficlent group may be found of a decrease in me­
thylated forms in favour of non-methylated forms. In the 
folic acid supplemented group one can observe an Increase 
in both methylated and non-methylated foly1 monoglutamates 
In comparison to the controls, buth the folylpolyglutamate 
level, markedly the methylated, decreased. 
The total brain folate level found by Bridgers and 
McClain (1972) and Obbens (1973), both about 0.2 ng/mg w.w., 
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was much lower than that found in our control group (mean 
value 1.272 ng/mg w.w.). The methylated folylpolyglutamate 
level, found by us in rat brain, is much higher 
(+ 10 times) than that found by Brîdgers and McClain 
(+ 0.1 ng/mg w.w.) in mouse brain. 
Considering the three diet groups as one experimental group, 
we are faced with two variables (the folate level and the 
seizure duration) in the application of the Spearman's rank 
correlation test. If one takes account of the groups as in-
dependent samples, the non-parametric monotonie trend test 
for independent samples (Ferguson, 1Э71) showes that the 
seizure duration is a monotonie increasing function of the 
folate level, indicating that any increment in the folate 
level is associated with an Increment in the seizure dura­
tion. 
(Ferguson, G.A. Statistical analysis in psychology and 
education. Third edition. McGraw-Hill Book Company, New 
York, 1971). 
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conjugase - conjugase + conjugate - conjugate 
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0.181. 
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О.ЙО 
Table 5 Seizure duration with the corresponding folate levels of plasma/serum, 
and brain before ( conjugase-) and after ( conjugase +) treatment with gamma-
carboxypeptidase ( exp.1178 ). 
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total methylated non-methylated 
0.159 0.116 0.0Ί3 
0.150 0.101 0.049 
0.212 0.156 0.056 
Ε9!ϊ!Β9!ϊ9ΐϋϊί!™ϊ£ΐ-ί!!9Λ!8-!ί;ϊι1 
total methylated non-methylated 
1.113 1.000 0.112 
1.091 0.977 о . т 
0.725 0.616 0.109 
l9Íii-Í9liÍSÍ-lDS¿ÍS.!?.:S;2 
total methylated non-methylated 
1.272 1.116 0.155 
1.2Ί1 1.078 0.163 
0.937 0.772 0 . 1 6 5 
Table 6 Mean cerebral folate values from table 5 
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2. INFLUENCES OF CHANGES IN DIETARY FOLATE LEVELS ON PENTETRA-
ZOLE-INDUCED THRESHOLDS AND MEGIMIDE-INDUCED SEIZURES 
(exp. 1195) 
In connection with the former experiments this series 
of experiments was set up to determine a possible influ­
ence of changed dietary folate levels on the EEG-thres-
holds induced by pentetrazole i.p. 
У?і!?2£!5_30<!-!РІІСГ!З.І5 
Three groups of rats were used: one which was fed on a 
folate-defIcient diet (0.4 mg folate/kg) for 11 months; 
one which was fed on a standard diet (2.7 mg folate/kg) for 
8 months; the other was fed on a folic acid supplemented 
diet (50 gr folate/kg) for 8 months. The rats on the fo­
late-def icient diet received sulphathiazole (3 gr/1) in 
their drinking water. During EEG-recording pentetrazole 
(concentration 10 mg/ml; pump-rate 1 ml/20 min.) was pumped 
i.p. to determine the first and second threshold, but be­
cause the first animals used in the experiment died rapid­
ly after the second threshold,with the remaining animals 
the i.p. pumping of pentetrazole was stopped immediately 
after appearing of the first paroxysmal bilateral syn­
chronic discharges in the EEG. 
In all the surviving animals a generalized seizure was 
evoked 1 month after the threshold-determination; the dose 
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of 7 mg meg imide/kg body weight was calculated at the mean 
body weight of the control group (2^9 gr). The mean body 
weight of the folate-deficient and the folic acid supple­
mented group at that moment amounted to 186 and 229 gr res­
pectively. 
Results 
Fig. 11 represents the received doses pentetrazole/kg 
body weight of each animal. It appeared that the folic acid 
supplemented rats received a significantly lower amount of 
dose/kg body 
might 
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Fig.11 The received doses pentetrazole/kg body weight at the first EEG-threshold. 
( exp.1195 I 
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pentetrazole compared to the control group (Wllcoxon's two 
sample test 0.1>p>0.05)· The folate-def¡cient rats receiv-
ed a significant higher amount of the convulsant drug com-
pared to the control group (Wilcoxon's two sample test 
0.05>p>0.02). Moreover, a significant negative correla-
tion (control + folate-deficlent + folic acid supplemented 
group) between the received dose pentetrazole/kg body weight 
and the serum folate level (L.casei, S.faecal is and L.casei 
minus S.faecal is) was observed (Spearman's rank correlation 
0.01>p>0.001 for all the correlations; fig. 12). 
The mean gain in body weight (20 gr.) of the folate-de-
ficient group during 11 months of diet (initial mean body 
weight 166 gr.) was much lower than the comparable folate-
def icient group in the former experiment (exp. 1178). Si-
milarly, the mean serum folate level (L.casei: 6.2 ng/ml) 
I Щ I 
• MM-MICIIlit 
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Fig.12 Relation between pentetrazole-induced first threshold and serum folate 
level ( semi-logarithmic,exp. 1195). 
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was lower. In table 7 the obtained data of the three groups 
are summarized. 
Of the meg im i de-induced seizures of the several groups 
no statistical difference could be observed in seizure dura-
tion. The quotient seizure duration: proper received dose 
megimide/kg body weight of each animal was significantly 
lower in the folate-deficient group compared to the folate-
supplemented group (Wilcoxon's two sample test 0.02>p>0.01). 
A significant negative correlation was found between the 
proper received dose/kg body weight and the serum folate 
level (L.easel, S.faecal Is and L.easel minus S.faecal is; 
Spearman's rank correlation 0.01>p>0.001 for control + 
folate-def ¡dent + folic acid supplemented group). 
Se 
L.c«*tl 
(nj/ml) 
S2.7 
56.7 
66.9 
52.0 
<·Ί.5 
1.8.1 
59.3 
66.8 
58.5 
U.ì 
5Ί.7 
« . б 
Ίβ.5 
«.7.1 
38.5 
1.3.0 
CONTROL 
run 
S . f a e c a l l i 
(ng/ml) 
P e n t e t r a z o l e 
(mg/kg body weight) 
2.583 
2.518 
2.1.63 
2.126 
1.773 
2.885 
2.1.62 
1.802 
2 . 3 5 * 
2.777 
2.5<i0 
1.610 
3.057 
2.060 
1.5*5 
1.861. 
'OLATE-DEFIC 
Serum 
L.easel 
(ng/ml) 
1 1 . Ί 
S.faecal Is 
(ng/ml) 
5.5 
5.3 
<..7 
-
Ί.5 
5.9 
-
5.6 
ІІ.2 
6.3 
3.0 
3.0 
-
-
3.0 
4.2 
ENT 
Pentetrazole 
(mg/kg body weight) 
1.338 
2.695 
2.707 
2.0Í.7 
2.805 
3.572 
3.057 
3.M.9 
Ί . 687 
3.281 
5.828 
2.623 
2.729 
3.021 
1.862 
1.798 
1.625 
2.799' 
FOLIC 
Se 
L.casel 
(ng/ml) 
580 
564 
582 
514 
499 
640 
628 
512 
887 
601 
541 
472 
656 
532 
761 
749 
ACID SUPPLEMENTED 
rum 
S.faecal Is 
(ng/ml) 
4J7 
426 
446 
326 
358 
448 
420 
436 
721 
523 
479 
379 
493 
392 
599 
626 
P e n t e t r a z o l e 
(mg/kg body weight) 
1.688 
2.628 
1.684 
1.514 
2.319 
1.746 
1.922 
1.391 
2.401 
3.138 
2.072 
2.404 
1.572 
2.318 
1.034 
2.147 
Table 7 First pentetrazole threshold values ( mg/kg body weight ) with the 
corresponding serum folate levels ( exp 1195 ). 
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3. INFLUENCE OF DIETARY VITAMIN B12 AND METHIONINE DEFICIENCY 
ON MEGIMIDE-INDUCED SEIZURES AND PENTETRAZOLE-INDUCED THRES­
HOLDS (exp. 1208) 
A comparatively greater depletion of folylpolyglutama-
tes rather than the corresponding folylmonoglutamates due 
to a vitamin B12 depletion was found by Jeejeeboy et al 
(I965) in human red cells and by Kutzbach et al (іЗб?) in 
rat liver. Thenen and Stokstad (1973) induced experimen­
tally a deficiency of the folyl-di-,-tri-, and -penta-
glutamates in liver cells of rats which were fed on a diet 
deficient of vitamin B12 and methionine. Little change oc­
curred in the level of the fol y1 monoglutamates. The gain 
in body weight of these double-deficient animals was re­
tarded. Elevation of methylmalonic acid and formiminoglu-
tamlc acid in the urine indicated a vitamin B12 deficiency 
and a secondary folate deficiency respectively. In serum, 
the level of 5-methylTHF was elevated. Added dietary me­
thionine or vitamin B12 both produced a rapid restoration 
of these folylpolyglutamates. Methionine, however, seems 
to be the primary factor affecting the uptake and storage 
of folates (Gawthorne and Stokstad, 1971)· A decrease in 
5-methyltransferase and SAM was observed In the liver of 
vitamin B12 deficient sheep (Gawthorne and Smith, 197М. 
With this vitamin B12 and methionine deficient diet it 
should be possible to determine the influence of a secon­
dary induced folylpolyglutamate deficiency on epileptic 
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manifestations. 
In 25 rats a generalized seizure was induced by i.v. 
injecting megimide in a dose of 7 mg/kg body weight. The 
duration and the nature of the seizures was measured by 
observation. This series of seizures served as control va­
lues. Immediately thereafter the rats were fed on a vita­
min B12 and methionine deficient diet, equal to that used 
by Thenen and Stokstad (1973). After the 4 t h , 8 t h and 12 t h 
week the megimide seizures were again evoked in the survi­
ving animals. The scoring method was the same as in the 
former experiments. 3 Months after the last seizure was e-
voked, pentetrazole was pumped i.p. in a concentration of 
10 mg/ml and at a rate of 1 ml/20 min. under EEG-recording 
In 10 randomly picked rats. For a statistical comparison a 
control group had to be formed, which unavoidably was 5 
months younger than the experiment group. 
Results 
Statistical analyses (Wilcoxon's paired test) revealed 
no differences in the duration of the megimide seizures 
before and after starting the diet. Serum folate levels 
of blood samples taken after the last seizure appeared to 
be slightly increased (L.casei activity mean value 62.3 
ng/ml; S.faecal is activity mean value 26.9 ng/ml) compared 
to the control group of exp. 1178 ('»З.З and І^.б ng/ml 
dose/kg 
body weight 
( mg ) 
10 0 
9 5 J 
9 0_ 
8 5_ 
8 0. 
7 5_ 
7 0. 
6 5_ 
6 Oj 
5 5j 
5 0. 
4 5. 
4 Oj 
3 5j 
3 0_ 
2 5 
2 0_ 
15J 
I tL 
5_ 
0 
first threshold second threshold 
control βχρ. control rap. 
Fig.13 The received doses pentetrazole/kg body weight, representing the first 
and second threshold of control rats and rats fed on a vitamin B ^ and methionine 
deficient diet (exp.1208) 
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respectively; table 5). 
The received doses pentetrazole/kg body weight (fig. 13), 
necessary to evoke the two thresholds, were significantly 
lower in the animals fed on the double-deficient diet (Wil-
coxon's two sample test: 0.1>p>0.05 and 0.05>p>0.02 respec-
tively) . 
8 Months after starting the diet,10 rats were randomly 
picked and killed under aether-anaesthesia. Serum vitamin 
B12 levels were measured (determination in the laboratory 
of Paediatrics) and found to be decreased by 80% in the 
experiment group (table 8). The brain folate determinations 
of 5 rats may indicate slightly an increase of folylmono-
glutamates at the cost of folylpolyglutama tes (table 9) 
compared to control values in table 5· The mean total brain 
folate level, however, was in the same range as that of the 
controls of exp. 1178 (1.2/2 ng/mg w.w.; table 5). This 
slight indication might support the results of the thres-
hold determination test. 
Because of the consideration that in the pentetrazole 
threshold determination test the difference in age be-
tween the experiment and control group might be respon-
sible for the observed differences between both groups, 
determination of the first threshold (exp. 1223) was per-
formed in animals (WAG/Rij rats) of different age (3, 8, 
12 and 18 months) in collaboration with drs. W. de Jong. 
It appeared that the pentetrazole-induced first thres-
hold in these k groups tended to lower when the animals 
were older, but the observed differences were not statis-
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tically significant. 
Therefore one can assume that the age difference between 
the vitamin B12 and methionine deficient animals and the 
control group is not the causative factor for the observed 
differences in the first and second threshold. 
Later, a generalized seizure was Induced with meg im i de 
(7 mg/kg body weight) in the same WAG/Rij rats (exp. 122Ό. 
With increasing age a decrease could be observed in the 
seizure duration, but also these differences were statis­
tically not significant. 
control exp. 
1325 
1265 
1525 
1600 
16 АО 
3^5 
173 
188 
370 
110 
Table 8 Serum vitamin B ^ levels ( pg/ml ) 
L.casei S.faecal is 
çgnjugase_; 
0.217 
0.230 
0.192 
0.189 
0.253 
Mean values: 
çgnjugase_+ 
1.í»69 
1.129 
1.372 
1.120 
1.275 
çgnjugase_; 
0.060 
0.063 
0.067 
0.059 
0.073 
conjugase_+ 
0.233 
0.111 
0.195 
0.168 
0.116 
fo l yImonog Iutama tes fo l y 1 polyg1utamates t o t a l f o l a t e s 
Î 2 î f i ÎPÉî!?i DQDlITfíbi ΐ 2 ί ? ί ¡TÊÏbi D?[3I!PCSb¿ І 0 І ? І ÎPfîtîi D2î?I,T,et!?.: 
0.216 0.152 0.06*» 1.057 0.956 0.101 1.273 1.108 0.165 
Table 9 Brain folate levels of 5 rats ( ng / mg.w.w.). 
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4. INFLUENCE OF INTRAPERITONEALLY ADMINISTERED FOLIC ACID ON 
MEGIMIDE-INDUCED SEIZURES (Exp. 1205) 
Because of the fact that in the former experiments (exp. 
1178 and 1195) a prolongation of the seizure duration by 
dietary folic acid supplementation was not very impressive 
and also the fact that the rats excreted massive doses of 
folic acid (visible in the yellow-coloured faeces), in the 
following experiment i.p. injection of folic acid was pre-
ferred to get higher tissue folate levels. When we started 
experimenting the folate determinations of the former ex-
periments had not been determined. 
t)S£b9í!5_§D£L!P§ÍSrÍ§l§ 
In 15 rats a generalized seizure was evoked by injecting 
meg imi de І. . in a dose of 7 mg/kg body weight. The total 
duration and the nature of the seizure was measured by ob­
servation. These values served as a control. Thereafter 
the rats were daily injected with 15 mg folic acid i.p. and 
new seizures in the surviving animals were evoked In the 
I* and 8 week, the result being recorded and tabulated. 
No microbiological determinations were performed of folic 
acid and Its derivatives. 
seizure 
duration 
tminj 
23 
22 : 
21 J 
20 1 
19 J 
18 1 
17 J 
16 1 
m 
15 _ 
M 1 
i3 _: 
12 I . J_ 
io : 
9 ^ 
8 J ' . ~ 
7 : · * ;· 
6 j 
5 J 
4 J 
3 J 
2 J 
ι — ·· · · 
·· · · 
0 ··" 
0 4 8 weeks 
Fig.14 The durations of megimide-induced seizures before and after 
daily treatment with 15 mg folic acid i.p. ( exp 1205 ). 
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Resyjts 
Fig. Il* represents the seizure duration before and after 
treatment with 15 mg folic acid i.p. A strong increase was 
seen, which was statistically significant (table 10). The 
points on the X-axis represents zero-values (no epileptic 
manifestation at all). The percentage tonic-clonic seizu-
res in seizure 1, 2 and 3 amounted to 1*7, 85 and 82 res-
pectively, the remainder being clonic seizures and zero-
values. 
s e i z u r e 
1 
2 
3 
1 
-
p<0.01 
p=0 .1 
2 
-
n . s . 
3 
-
Table 10 Wilcoxon's paired test. 
Seizure duration before < seizure 1 ) and after ( seizure 2 and 3 ) daily doses 
of 15 mg.folic acid i.p. ( n.s.' not significant ). 
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5. INFLUENCE OF CHANGES IN THE FOLYLPOLYGLUTAMATE TISSUE LEVEL 
BY DIETHYLNITROSAMINE ON MEGIMIDE-INDUCED SEIZURES (exp.1231») 
Poirier and Whitehead (1973) reported that In rats trea-
ted chronically ( 1 - 5 weeks) with diethylnitrosamine ( a 
hepatocare inogen, which was added to the drinking water) 
the hepatic content of the folylpolyglutamates decreased 
without affecting the folylmonoglutamate content. Assuming 
that such a decrease should also occur in other tissues In-
cluding the brain, we treated the rats orally with this che-
mical for 12 weeks. However, no influence could be observed 
on repeatedly induced megimide-seizures. Brain tissues of 
these animals were collected but folate determinations have 
yet to be performed. If Poirier's and Whitehead's findings 
can be confirmed,this should Indicate that only changes in 
brain folylmonoglutamate levels can influence generalized 
seizure activity. 
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6. SUMMARY 
¿nduçed_sejzures 
No definite conclusion could be drawn from the profile analy-
sis but the test slightly indicates a protective action of a 
folate-deficient diet against meg im i de-induced seizure duration. 
Furthermore the mean seizure duration (seizure 2 - 1 1 ) was 
in the folate-deficient group significantly lower than in 
the control group. Overloading of the folate-deficient 
group with meg im i de compared to the other groups (seizure 
12) yielded nevertheless a significantly shorter seizure 
duration compared to the folic acid supplemented group. 
Positive correlations were found between the seizure dura-
tion and the serum folate level (total, methylated and non-
methylated) as well as the methylated folylmonoglutamate 
(5-methylTHF) levels of the brain. Folic acid supplementa-
tion lowered the total brain folate level which was due to 
a decrease in the folylpolyglutamate content, but the fo-
lylmonoglutamate level raised. Folate-withdrawal seems to 
lower the level of methylated forms of the folylmonogluta-
mates in favour of non-methylated forms. The total brain 
folate levels found by us were much higher than those gi-
ven in other literature, as well as the methylated folyl-
polyglutamate levels. 
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The received doses pentetrazole/kg body weight, necessa-
ry to evoke paroxysmal bilateral synchronic discharges, 
were significantly lower in the folic acid supplemented 
group and significantly higher In the folate-def¡cient 
group; both were compared to the control group. Also a 
significant negative correlation was found between the re-
ceived doses of pentetrazole/kg body weight and the serum 
folate level (total, methylated and non-methylated). 
No statistical differences were found in the duration 
of meg imi de-induced seizures of the 3 groups, but the quo-
tient seizure duration: proper received dose meglmide/kg 
body weight was markedly lower In the folate-deficient 
group compared to the folic acid supplemented group. An-
other significant negative correlation was found between 
the proper received dose meglmide/kg body weight and the 
serum folate level (total, methylated and non-methylated). 
lDfiyfDC§_2f_£b5D9§^_^ÌSÌ§rx_yÌÌf!PÌD_§12_5D^_!PSÌbÌ9DÌDS 
ÌEySÌ§_2D_!PS9Ì!Pl^EIÌD^ySf^_5?I?yrS§_§D^_BeDÌSÌr§29lSlÌDl 
síy£SíLí!?rs§i}9líí§ 
The duration of megimide-induced seizures did not 
change under the influence of a vitamin B12 and methio-
nlne-deficient diet. Serum folate levels (total, methyla-
ted and non-methylated) appeared to be slightly raised 
after 3 months of diet. 
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The received doses pentetrazole/kg body weight, neces-
sary to evoke paroxysmal bilateral synchronic discharges 
and generalized clonic seizures, were also lower in the 
double-deficient group compared to a 5 months younger con-
trol group, but the difference in age did not appear to be 
a critical factor. 
A vitamin B12 and methionine deficient diet seems to 
elevate the folylmonoglutamates at the cost of folylpoly-
glutamates, without affecting the total brain folate le-
vel . 
Later performed experiments (in collaboration with drs. 
A. van Straten) revealed that in rats fed on a vitamin B12 
and methionine-deficient diet for one year after injecting 
125 mg folic acid i.v. the first paroxysmal bilateral syn-
chronic discharges and primary generalized seizures occur-
red earlier compared to controls (unpublished results), in-
dicating again that increased doses of methylated monoglu-
tamates might lower both thresholds. 
seizures 
High doses of daily I.p. Injected folic add (IS mg) 
markedly prolonged the duration of meglmide-induced seizures. 
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bí_ÍÍISí!3XÍD.ÍÍE2§§!FÍ!3§_9D_!P§9Í!?iííSIÍDí!ySSSL§E.iíyíSS 
No influence was observed In megImide-induced seizures 
during chronic treatment with hepatocarclnogen. However, 
a definite conclusion can not be drawn because of Insuf-
f icient brain folate values. 
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C H A P T E R 10 
INFLUENCE OF PARTIAL HEPATECTOMY AND LIGATURE OF tHE PORTAL 
VEIN ON FOLATE-INDUCED EPILEPSY (exp. 1192 and 1235) 
A partial hepatectomy or a ligature of the portal vein 
has strongly inhibitory actions on fol ate-Induced primary 
generalized epilepsy in normal rats (Obbens, 1973; Hommes 
and Obbens, 1973): a partial hepatectomy reduced complete-
ly generalized seizure discharges in the EEG, evoked by 
125 mg Na-folate, but frequent paroxysmal generalized dis-
charges of low voltage were still observable. A ligature 
of the portal vein completely reduced these latter epilep-
tiform discharges in the EEG. Seizure susceptibility to 
pentetrazole was not suppressed compared to rats with a 
sham-operation. Hommes and Obbens suggested that in nor-
mal rats without brain lesions the epileptogenic effect 
of Na-folate in very high doses is dependent on Its con-
version to S-methylTHF in the liver. 
If we assume that the liver makes a strong epileptoge-
nic derivative (5-methylTHF) from administered folic acid 
and that this derivative is responsible for the generali-
zed seizures induced by very high doses of folic acid in 
normal rats and with this in mind, it Is possible that in 
rats with a folate-activated cortical heat lesion, the 
focal or secondary generalized seizures in the EEG are al-
so due to this epileptogenic substance. According to this 
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postulate one can expect that hepatectomy or portal vein 
ligature reduces the folate-!nduced focal or secondary ge-
neralized EEG-seizures without affecting the activity of 
the focus itself. Therefore experiments were done to stu-
dy the effects of hepatectomy and portal vein ligature on 
a folate-activated cortical heat lesion in rat brain. 
In each animal in a group of 17 rats a cortical heat 
lesion was made and 3.5 hours later a partial hepatectomy or 
sham-operation was performed. Then a dose of 15 mg folic 
add was injected i.v. under EEG-recording, 30 - 60 min. 
after the operation. 
Another group of 25 rats was treated in the same way, 
but this time the i.v. injected dose of folic acid amount-
ed to 30 mg. 
In the EEG the total seizure activity was measured for 
30 min. 
Resu]ts 
In both groups a positive significant correlation was 
found between the percentage of remaining liver and the 
total seizure activity in the 30 min. EEG-recordings 
(Spearman's rank correlation, 0.05>p>0.02 and p<0.01 res-
pectively), also when the values of the sham-operated rats 
were excluded. No correlation existed between the time of 
appearance of the first focal spike and the percentage of 
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Fig.15 The total seizure activity in 30 min.EEG-recording of hepatectomized and 
sham-operated rats with a fol ate-activated cortical heat lesion ( exp. 1192 + 1235 ). 
remaining 1¡ver. 
In fig. 15 the relation is schematically represented. 
A dissection of about 1/3 of the liver Is enough to nulli-
fy seizure activity from an activated cortical focus, but 
It must be pointed out that the focal spikes Itself re-
mained unaffected by the partial hepatectomy. Because of 
the statistical difference in percentage of the remaining 
liver between both groups, it was not possible to compare 
the EEG-data from both groups with the Wilcoxon's test. 
In rats receiving a ligature of the portal vein it ap-
peared that with injecting I.v. 15 mg or 60 mg of folic 
acid, a cortical heat lesion could be activated, but no 
seizure activity was observed. The time for the appearance 
of the first focal spike was significantly shorter in the 
group with 60 mg folic acid (Wilcoxon's two sample test 
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p<0.01) compared to the group with 15 mg folic acid. 
Summary 
A partial hepatectomy markedly decreased seizure acti-
vity from a folate-activated cortical heat lesion without 
affecting the solitary focal discharges. A positive cor-
relation was observed between the total seizure activity 
in 30 min. of EEG-recordlng and the percentage of the re-
maining I ¡ver. 
The effect of a portal vein 1igature on the seizure 
activity from such a focus was more pronounced. 
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C H A P T E R 11 
INFLUENCE OF METHOTREXATE AND PYRIMETHAMINE ON A FOLATE-
ACTIVATED CORTICAL HEAT LESION. THE EPILEPTOGENIC ACTION 
OF PYRIMETHAMINE ITSELF (exp. II83, US'», 1186, 1187, 
II89, II90 and 124(3) 
Methotrexate (MTX), a folic acid analogue used In chemo­
therapy of psoriasis and cancer, and pyrimethamine (PM), 
a pyrimidine derivative used in the therapy of malaria, 
are both inhibitors of dihydrofolate-reductase. Obbens 
(І97З) tested these compounds and their possible anti-
epileptogenlc effect against Na-folate-induced epilepsy: 
pretreatment with MTX i.m. or i.v. showed no inhibition 
of Na-folate-induced epilepsy in normal rats, whereas after 
PM-treatment l.cort. in rats with a Na-folate activated 
cortical heat lesion, the time for the appearance of the 
first focal spike was found to be later then that of the 
controls. MTX itself can evoke epilepsy when injected 
l.cort. (Obbens, 1973; Obbens and Hommes, 1973). 
Because of the reduction of seizure activity from a 
folate-activated cortical focus by partial hepatectomy 
or portal vein ligature and the fact that folic acid is 
converted to S-methylTHF in the liver, one can expect 
from above-described experiments that inhibition of li­
ver dihydrofolate-reductase by MTX or PM reduces seizure 
activity in rats with a folate-activated cortical focus. 
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PH itself can evoke convulsions in human, when intoxi-
cated by this compound (Goodman and Gilman, 1965)· There-
fore we tested this substance and Its epileptogenic action. 
Methotrexate and a folate-actlvated cortical heat lesion 
Î?§îb9ÎÎ§.i-!P3££ri§l5_§DiLrS§yIî5 
Two groups, each of 9 rats, received under EEG-recording 
15 mg folic acid, k hours after a cortical heat lesion. 
One group was pretreated with 1 mg MTX i.V., 24 hours be-
fore the Injection of the folic acid; the other with 1 mg 
MTX i.V., 1 hour before the injection of the folic acid. 
In the EEG, the time of appearance of the first focal spike 
and the total seizure activity for 30 min. was measured. 
The obtained data were statistically compared to those of 
a control group and mutually. 
Using the Wllcoxon's two sample test and comparing the 
control and the test groups, we found no significant dif-
ference In the time of appearance of the first focal spike 
and the total seizure activity In the 30 min. duration of 
the EEG. 
Pyrimethamine and a folate-activated cortical heat lesion 
ÎÎÊÎbSiJS.i-MSÊriâ.lS-âOSLrSSylÎS 
One group of 11 rats received 1 mg PM i.V., 24 hours 
before activation of a k hour-old cortical heat lesion 
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by folic acid. A second group of 11 rats received 1 mg PH/ 
kg body weight i.V., and a third group of 10 rats received 
0.1 mg PH/kg body weight, both these groups being injected 
2k hours before the activation by folic acid. The duration 
for the appearance of the first focal spike and the total 
seizure activity for 30 min. was measured from the EEG. 
The obtained data from all groups were statistically corn-
par ed, and to those of a control group. 
Using the Wllcoxon's two sample test, no significant 
differences were found, which Is in contrast to the fin-
dings of Obbens (1973). We also found that 1 mg of i.v. 
injected PM did not activate a k hour-old cortical heat 
lesion. 
Pyrimethamine I.v. and l.cist. in normal rats 
A group of 9 rats was injected i.clst. with PM in doses 
varying from 0.3 " 1 mg. No epilepsy was observed In the 
30 min. following the injection. 
Another group of 7 rats was injected i.v. with a dose 
of 3 mg PH. All animals reacted within 85 sees, and demon-
strated seizures of generalized clonic character alterna-
ting with psychomotor disturbances (smelling, licking, 
chewing, screaming, sly crawling and retreating movements, 
sitting on their hind-limbs and then falling backwards). 
Hands-clapping evoked opisthotonus, violent clonic move-
ments and screaming. The time of duration of these epi-
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leptic phenomena ranged to more than 60 min. in 2 the 
animals, the others dying within this period. 
Because of the striking difference between i.v. and 
i.cist. injected PM and the 'flush-out' of folates under 
influence of analogues (see chapter i»), the role of the 
liver in these epilepsies had to be investigated. 
Pyrimethamine and a ligature of the portal vein 
The portal vein was 1 ¡gated in a group of 8 rats. PM 
was injected i.v. in doses of 3 mg within bS ~ 60 min. 
after the operation. Two animals showed very weak epi-
leptic reactions, 25 sees, and k min. respectively after 
the injection. The duration of these seizures was 130 
and 600 sees, respectively. No epilepsy was observed in 
the other 6 rats. 
In contrast,a group of 8 sham-operated rats showed vio-
lent clonic seizures (characteristically the same as those 
described above) with a mean time duration of 35 min., but 
none of these animals died. 
Pyrimethamine and partial hepatectomy 
A partial hepatectomy was performed on 8 rats. Within 
30 - 60 min. after the operation, 3 nig PM was injected i.v. 
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The clinical observed seizures started 15 - 115 sees, af-
ter the injection and a positive significant correlation 
was found between the percentage of remaining liver and 
the seizure duration (Spearman's rank correlation 
0.05>p>0.02). 
The epilepsy in this experiment was not completely re-
duced even after a partial hepatectomy of more than 75%· 
Because the epileptogenic action of PM appears to be 
partially dependent on the presence of the liver, it is 
not unimaginable that its mode of action is due to ex-
pelling folate from its tissue bindings. An incompleted 
series of experiments (in collaboration with drs. Th. 
van de Wiel) supports this suggestion. 
Summary 
MTX as well as PM does not inhibit folate-induced epi-
lepsy in rats with a cortical heat lesion. 
PM i.v. in normal rats induces generalized clonic sei-
zures alternating with psychomotor disturbances, but not 
when injected i.eist. A ligature of the portal vein mar-
kedly reduces these seizures and psychomotor disturbances, 
while after a partial hepatectomy a significant positive 
correlation exists between seizure duration and the mass 
percentage of the remaining liver. 
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C H A P T E R 12 
INFLUENCE OF DIPHENYLHYDANTOIN ON A FOLATE-ACTIVATED CORTI­
CAL HEAT LESION (exp. ligi», II98 and 1200) 
Obbens (І97З) tested the antiepileptogenic efficacy of 
DPH on focal epilepsy, which was evoked in normal rats by 
i.cort. injecting folic acid or by l.v. injecting folic 
acid in rats with a cortical heat lesion. The animals were 
given daily doses of 50 mg DPH orally for 1 month. When a 
comparison was done with the control group, which received 
no anticonvulsant, no significant differences could be 
found either in the number of i.cort. injections neces­
sary to evoke epilepsy or in the time for the appearance 
of the first epileptic focal spike and the scores of sei­
zure activity in the EEG in the rats with a folate-actl-
vated cortical heat lesion. 
On the other hand we were able to prevent the appea­
rance of seizures from a folate-act i vated cortical heat 
lesion by a partial hepatectomy of more than 35% or by a 
portal vein ligature, whereas there was no change in the 
solitary focal discharges. These experiments support the 
suggestion that 5-methylTHF from by the liver converted 
folic acid is responsible for this seizure activity. 
DPH is thought to prevent the spread of seizure discharge 
by inhibiting postsynaptic potentiation (Esplín, 1957). 
Moreover DPH affects the folate metabolism, but the mode 
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of action is still unknown. The suggestion was then made 
that DPH reproduces the action of partial hepatectomy on 
a folate-activated cortical heat lesion: DPH inhibits sei­
zure discharge from a folate-activated cortical heat le­
sion by counteracting the action of 5-niethylTHF. 
Two chronic and two acute experiments with rats were 
set up. All the animals received under EEG-recording an 
l.v. injection of 15 nig folic acid, Ц hours after a cor­
tical heat lesion. The only difference in this experi­
ment being the pretreatment with DPH: one group of rats 
was given dally doses of 25 nig DPH-Na orally for 1 month, 
while another group of rats was pretreated with 50 mg 
DPH-Na. In the acute experiments a group of rats was 
injected i.v. with 12.5 mg of the same stock-solution 
of DPH-Na within 15 min. preceding the injection of fo­
lic acid, while another group of rats was pretreated si­
milarly with 12.5 mg Epanutin (DPH-sodium BP in glycol­
sol ution; Parke-Davis). The EEG of each animal was mea­
sured and recorded for 30 min. as follows: 
- time of appearance of the first focal spike 
- time of appearance of the first seizure 
- number of seizures in 30 min. EEG-recording 
- duration of each seizure separately 
- total amount of discharges ¡n each seizure 
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- maximal amount of discharges/sec, measured In the part 
with the highest frequency (varying from 3 ~ 15 sees.), 
in each seizure 
- total seizure activity in 30 min. EEG-recordlng. 
The obtained values were statistically compared, also with 
those of a control group (exp. 1188). 
The injecting times of DPH-Na and Epanutin within the acute 
experiments before the folic acid injections were not sta-
tistically significant. 
Resu]ts 
Time of appearance of the first focal spike 
Fig. 16 represents the obtained EEG-data of each animal 
within the different groups. In table 11 the results of 
statistical analyses with the Wllcoxon's two sample test 
are summarized. It appeared that after chronic oral treat-
ment with DPH-Na the time of appearance of the first fo-
cal spike occurred earlier compared to that of the con-
trol group, whereas single t.v. Injections with Epanutin 
retarded them. No influence was apparent from pretrea-
tlng the rats with 12.5 mg of DPH-Na i.v. The observed 
differences between the two t.v. Injected DPH-solutlons 
In the acute experiments led to the testing of the gly-
col-solutlon (solvent of Epanutin). The same method and 
volume (o.25 ml) I.v. was used as in the animals treated 
with 12.5 mg Epanutin. Although no significant difference 
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Fig.16 The time of appearance of the first focal spike in the EEG of rats with a 
folate-activated cortical heat lesion under different DPH-treatments 
( exp. 1194,1198 a+b, 1200 ), no treatment ( exp. 1188 ), Epanutin-solvent 
( exp. 1198 с ) and SAM ( exp. 1197 ). 
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Fig.17 The time of appearance of the first EEG-seizure of rats with a folate-activated 
cortical heat lesion under different DPH-treatments ( exp. 1194,1198 a+b, 1200 ) 
no treatment ( exp. 1188 ), Epanutin-solvent (exp. 1198 с I and SAM (exp. 1197 ). 
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with the control group was found (table 11), schematical 
representation (fig. 16) does suspect a retarding effect 
of this solvent on the time for the appearance of the 
first focal spike. 
Time of appearance of the first seizure 
In fig. 17 the time of appearance of the first seizure 
is schematically represented, while in table 12 the re­
sults of statistical comparisons are summarized. 
It can be concluded that ΟΡΗ does not influence the 
time of appearance of the first seizure. 
Number of seizures in 30 min. EEG-recording 
Fig. 18 represents the number of seizures in 30 min. 
EEG-recording including the zero-values on the abscissa 
^ -I CONTROL CHRONICALLY CHRONICALLY АСШЕ ACUTE ACUTÍ ACUTE 
N u m b e i Of JSmqDPHNa S f n q D P H N j 12 5 гн) DPH Na 12 5 ng EPAHUTU 11 4 mg SAM 
seizures/rrt ' " p ° " E P A N U T I N , » S O L V E N T I * .» 
0 J 
Fig 18 The number of seizures in 30 mm EEG-recording of rats with a folate-açtivated 
cortical heat lesion under different DPH-treatments ( exp 1194,1198 a+b, 1200 ), no 
treatment ( exp 1188 >, Epanutm-solvent ( exp 1198 с I and SAM ( exp. 1197 h 
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(rats without seizures in the EEG). In the statistical 
analyses (table 13) these zero-values are inserted. 
In the acute experiments a very small number of rats 
showed seizures in the EEG, indicating a very effective 
suppression of the folate-induced seizures by the anti-
convulsant. Also in the rats treated with the Epanutin-
solvent only a small number of the rats surprisingly 
showed seizures in the EEG. 
However, when these zero-values are excluded, it can 
be observed (fig. 18a) that there is an increase in the 
mean number of seizures in the 30 min. EEG-recording in 
rats treated chronically with DPH compared to the con-
trols, whereas the mean number of seizures in rats treat-
ed with high i.v. doses of the anticonvulsant decreased 
compared to the controls. Also in the Epanutin-solvent 
group, this can be observed. 
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Fig.20The total amount of discharges in EEG-seizures of rats with a fol ate-activated 
cortical heat lesion under different DPH-treatments ( exp. 1194,1198 a+b, 1200 ), 
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112 
Duration of each seizure separately 
The duration of each seizure separately is represented 
in fig. 19» while the statistical results are summarized 
in table 1^. It can be observed that by both chronical and 
acute DPH-treatments the duration of folate-induced seizu-
res is considerably shortened. The results of the Epanutin-
solvent group showed no difference when compared to those 
of the control group. 
Total amount of discharges in each seizure 
Fig. 20 represents the total amount of discharges In 
each seizure, which decreases significantly when the ani-
mals were treated with DPH (table 15). Also rats in the 
Epanutin-solvent group showed a significant difference 
with the controls. 
Maximal amount of discharges/sec, measured in the part 
with the highest frequency, in each seizure 
This maximal amount of discharges/sec. is schematically 
represented in fig. 21. Chronic DPH-treatment reduced it, 
but after a single high dose of DPH-Na or Epanutin i.v. 
this reduction disappeared (table 16). In the group with 
Epanutin-solvent a reduction was also observed. 
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Fig.22The total seizure activity in 30 min.EEG-recording of rats with a 
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Fig.21 The maximal amount of discnarges/sec., m tne part with the highest 
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Total seizure activity ¡n 30 min. EEG-recording 
The total seizure activity (fig. 22) was significantly 
reduced by high i.v. doses of DPH (table 17) compared to 
the controls. This effect was not achieved in rats with 
chronic DPH-treatment. The Epanutin-solvent also reprodu-
ced a reduction of the total seizure activity. 
Total focal activity in 30 min. EEG-recordìng 
It seemed that in rats treated with DPH the focus was 
more active in producing solitary focal discharges compar-
ed to that of the controls, but because of extinction of 
the focus immediately after each seizure, an acceptable 
scoring-method could not be found. 
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Fig.23Alteration in seizure-pattern ( A:control; В and С: DPH treatment). 
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In fig. 23, the alteration in the pattern of seizures 
from a folate-activated cortical heat lesion by DPH 
treatment is represented. It can be seen that if seizu-
res develop, they are shorter in duration and contain 
less discharges. The time between each discharge is 
longer than in the normal seizures. It suggests that 
DPH and Epanutin split up the seizures in smaller units 
with less discharges, although the total number of epi-
leptic discharges in the EEG (unlike the seizures) seems 
not to decrease. This again would indicate a differential 
mechanism for discharge and seizure formation, of which 
only the seizure formation is influenced by DPH. As strong 
indications were found that this seizure formation in fo-
late-epilepsy is dependent on 5-methylTHF, the findings 
in this chapter produce strong evidence that the effect 
of DPH on the folate focus is mediated via an effect of 
DPH on 5-methylTHF. 
SUMMARY 
The time of appearance of the first epileptic focal 
spike occurred earlier when the rats were treated chro-
nically with DPH and later with a single Epanutin injec-
tion, both compared to the control group. A single inject-
ed dose of DPH-Na i.v. had no influence, although the Epa-
nutin-solvent also did seem to have some sort of retarding 
effects on the time of appearance of the first focal spike. 
The time of appearance of the first seizure is not in-
fluenced by DPH. 
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The mean number of seizures during 30 min. EEG-record-
ing of rats with seizure activity increases after chroni­
cal treatment with ΟΡΗ, but single doses of i.v. DPH de­
crease it. This latter effect can also be reproduced by 
the Epanutin-solvent. 
The duration of seizures was shortened by DPH, but not 
by the Epanutin-solvent. 
The total amount of discharges in each seizure was de­
creased by DPH as well as by the Epanutin-solvent. 
The maximal amount of discharges/sec. (measured in the 
part with the highest frequency of discharges) in each 
seizure is decreased by chronic treatment with DPH and 
by treatment with the Epanutin-solvent, but not by a 
single i.v. dose of DPH-Na. 
The total seizure activity during 30 min. EEG-recording 
was decreased by i.v. doses of DPH and i.v. doses of Epa-
nutin-solvent, but not by chronic DPH treatment. 
It seemed that the solitary focal discharges increased 
after treatment with DPH, but a definite conclusion can 
not be drawn because of the poor technical scoring methods. 
The solvent of Epanutin intensifies the action of DPH. 
In a group of 10 rats with a Ί hour old cortical heat 
lesion 12.5 mg phénobarbital i.v. reduced completely, 
folate-induced seizures. 
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Table 11 
Lont r o t 
L h r o n i t a ! 1 y 
Г, m4 OPH-hd 
L h r n n i c r f l ly 
A c u t e 
12. S mfj UPH-N* 
• 2 S " g tp*r>ut m 
A L U I * 
( p j n u t m - s o l v e n t 
Cont r o i 
-
ρ 0 01 
0 02>p 0 01 
η 4 
0 O S - p O 02 
η \ 
> r o n i c a l 1 y 
¡S mg DPH-Na 
π 4 
η \ 
p-0 01 
p. 0 01 
C h r o m e 11 1 y 
50 "iq OPH-N.! 
-
η ί 
ρ · 0 01 
P'O 01 
^ c u l e 
12 Λ mg DPh-Sa 
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P-0 01 
0 Oi-p.O 02 
A c u t e 
12 ,5 mr. [ p a n u t tn 
-
η S 
Acute 
Foanut n - s o l v e n t 
-
Table 11 Time of appearance of the first focal spike in the EEG. 
Table 12 
C o n t r o l 
C h r o n i c a l 1 y 
2Î» «*) ΟΡΗ-Nj 
C h r o n i c * ! 1 y 
',0 mg L»Ph-Na 
At ц t e 
W Ь my ÜPM-Nd 
A t o t e 
12 S "«g t p a n u t m 
Acute 
f p * n u t i n - s o l v e n t 
-
n . s . 
η s 
к 
к 
п . * . 
η ν 
п . , . 
-
M 
H 
п . s . 
-
• 
• я 
-
Table 12 Time of appearance of the first seizure in the EEG 
( n.sr not significant, χ · too small numbers for statistical comparison ). 
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Table 13 
C o n t r o l 
C h r o n i c a l l y 
2S " 4 OPH-Nj 
C h r o n i c a l l y 
SO fnq Ο Ρ Η - Ν Λ 
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0 Ι 'Ρ 0 Ob 
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Table 13 Number of seizures in 30 min.EEG-recording. 
Table 14 
C o n t r o l 
C h r o n i c a l l y 
25 mg DPH-Na 
C h r o n i c a l l y 
50 mg DPH-Na 
A c u t e 
1 2 . S «»g DPH-Na 
A c u t e 
1 2 . S mg E p a n u t i n 
A c u t e 
E p a n u t I n - s o l v e n t 
-
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ж 
П . 1 . 
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• 
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Table 14 Duration of each seizure separately. 
120 
Table 15 
C o n t r o l 
C h r o n i c a l 1 y 
Λ mt) l> Ρ Η-Nd 
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Table 15 Total amount of discharges ¡η each seizure. 
Table 16 
L o n t r p l 
C h r o m с a l l y 
2э ι -j üPH-Na 
C h r o n i c a l l y 
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Table 16 Maximal amount of discharges/sec. in each seizure. 
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Table 17 
C o n t r o l 
C h r o n i c a l l y 
25 mg ΟΡΗ-Ha 
C h r o n i c a l l y 
50 mg DPH-Na 
A c u t e 
12 5 mg ΟΡΗ-Na 
A c u t e 
12 5 mg f p a n j t i n 
A c u t e 
Epanut i n - s o l v e n t 
C o n t r o l 
-
η s 
η s 
p<0 01 
p<0 01 
η 5 
25 mg DPH-Na 
-
η S 
ρ<0 Ol 
ρ<0 Ol 
0 0S>p>0 02 
50 mg DPH-Na 
-
0 1>ρ>0 05 
0 05>ρ>0 02 
η s 
12 5 mg DPH-Na 
-
η S 
η \ 
12 5 mg E p a n u t i n 
-
η % 
Epanut ln-»o W e n t 
Table 17 Total seizure-activity m 30 min. EEG-recording. 
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C H A P T E R 13 
INFLUENCE OF S-ADENOSYLMETHIONINE (SAW) ON A FOLATE-
ACTIVATED CORTICAL HEAT LESION (exp. 1197) 
Kutzbach and Stokstad (196?) found in an in vitro expe-
riment that SAM at physiological concentration inhibits 
5.10-methylene-tetrahydrofolate-reductase of rat liver, 
thus preventing the accumulation of 5-niethylTHF. They pro-
posed that this inhibition by S A M ^ unct ions as a feedback-
type metabolic regulation in vivo and might explain partial-
ly the effects of methionine on folic acid metabolism. 
Baldessarini (1966) observed that i.p. injection of methio-
nine increased the level of SAM in such a way that it,in 
vitro^should result in a strong Inhibition of the enzyme. 
Buehring et al (1972) demonstrated that in the perfused 
livers of rats, which were fed on a vitamin B12-deficient 
diet, methionine - the precursor of SAM - did not influence 
the uptake of folic acid from the perfusion fluid into the 
liver, but it did increase the level of THF, 10-formylTHF 
and folylpolyglutamates while preventing the accumulation 
of 5-methylTHF. 
Thus one can expect that the conversion of an injected 
dose of folic acid to 5-methylTHF in the rat liver is in-
hibited by prior administration of SAM. In the folate-in-
duced focal epilepsy systerr^this feedback inhibition might 
lead to impairment of evoking seizures, which was similar-
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ly observed in the experiments with partial hepatectomy, 
ligature of the portal vein and DPH administration,with 
regard to a foiate-activated cortical heat lesion. 
A cortical heat lesion was performed in a group of 20 
rats; k hours before the activation of this focus by in-
jecting i.v. 15 mg folic acid. Within 10 min. preceding 
the folic acid Injection, each animal received a dose of 
11.4 mg SAM i.v. 
The readings of the EEG were recorded and measured for 
30 min. and the results tabulated as in the DPH experi-
ments. 
The obtained values were statistically compared with 
those of a control group (exp. 1188) and with the DPH-
groups (exp. 1194, II98 and 1200). The injecting time of 
SAM before the folic acid injection was comparable to those 
of the acute DPH experiments. 
The statistical compared results (table 18) have been 
represented in fig. 16, 17, 18, 19, 20, 21 and 22. 
It appears that SAM induces a strong reduction of sei-
zure activity from a folate-act iva ted cortical heat lesion. 
The few seizures, which were recorded, had the same cha-
racterisation as a control seizure. 
Later performed experiments (in collaboration with 
Time of appearance of the first focal 
spike 
Time of appearance of the first seizure 
Number of seizures In 30 min.EEC-record. 
Duration of each seizure separately 
Total amount of discharges in each selz. 
Намііла) amount of discharges,measured In 
the part with the highest freq.ln each 
seizure 
Tot.seizure-act. in 30 min. EEC-record. 
control 
n.s. 
X 
p<0.01 
n.s. 
n.s. 
n.s. 
p<0.0t 
chronically 
25 mg ΟΡΗ-Na 
0.02>p>0.01 
H 
p<0.01 
0.l>p>0.05 
n.s. 
n.s. 
p<0.0l 
chronically 
SO mg ΟΡΗ-Na 
0.05>p>0.02 
X 
p<0.01 
p<0.0l 
0.05>p>0.02 
n.s. 
0.t>p>0.05 
acute 
12.5 mg ΟΡΗ-Na 
n.s. 
X 
n.s. 
p<0.01 
n.s. 
n.s. 
n.s. 
acute 
12.5 mg Epanutin 
n.s. 
к 
n.s. 
X 
X 
X 
n.s. 
Table 18 Wilcoxon's two sample test. 
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drs. Α. van Straten) showed that the first paroxysmal bi­
lateral synchronic discharges and the primary generalized 
seizures, evoked by high i.V. doses of folic acid In rats 
without a cortical heat lesion, occurred earlier in con­
trol rats than in rats previously treated with SAM i.V. 
(unpublished experiments), thus confirming the effect of 
SAM in focal folate epileptic activity. 
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C H A P T E R Τ» 
THE EPILEPTOGENIC ACTION OF 5-METHYLTHF (ехр.П75 + 1191) 
In the experiments concerning the influence of a partial 
hepatectomy as well as a portal vein ligature on a folate-
activated cortical heat lesion, it is suggested that the 
conversion of folic acid Into S-methylTHF by the liver is 
essential for the occurrence of focal and secondary gene­
ralized seizures. The strong reduction of seizure activity 
by DPH and SAM resembles a 'chemical hepatectomy'. In rats 
fed on a folate-deficient or folic acid supplemented diet 
a positive correlation was shown between the serum folate 
(L.casei, S.faecal is and L.casei minus S.faecal is) as well 
as brain 5-methylTHF and the duration of meg imi de-induced 
seizures. For the epileptogenic action of PM, the presence 
of the 1iver was necessary. 
Because of all these findings the epileptogenic action 
of 5-methylTHF itself had to be investigated. 
5-methylTHF in normal rats 
??§î!?2S!§.i_!P§îir.i§l5_3D£Lrê§y!î§ 
A group of 10 rats was injected I.cist, with 0.02 mg 
5-methylTHF. Generalized tonic-clonic seizures, also alter-
nating with the earlier described psychomotor disturbances 
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(chapter 11), occurred ín 8 animals within 7 min. Death 
followed within '•O min. Another group of 10 rats, treated 
30 min. previously with 12.5 mg DPH-Na i.V., did not show 
any epilepsy signs after the same i.cist. dose of 5-methyl-
THF. 
In a group of 11 rats 5"niethylTHF was injected i.v. In 
doses varying from 3.75 ~ 7-5 mg under EEG-recording. Ad-
ministration of higher amounts in one dose was not pos-
sible because the heavy metal-ions of the 5-niethylTHF ba-
riumsalt are extremely toxic for the rat's heart. During 
the following 30 min. EEG-recordings, paroxysmal bilateral 
synchronic discharges were observed in 8 animals, of which 
7 reacted with a primary generalized seizure (10 - 25 min. 
after the injection, seizure duration >1 min.). 
5-methylTHF in rats with a cortical heat lesion 
ÍJ§í!39í!5.i_!I,§ÍErÍfl§_§DSLrS§yl£5 
20 Rats with a Ί hour-old cortical heat lesion were in­
jected under EEG-recording conditions with 5~fnethylTHF i.v., 
the total dose which ranged from 2 - 1 0 mg, being fully or 
partially injected till the total dose was required. Pa­
roxysmal bilateral synchronic discharges were observed in 11 
rats while in a group of 5 of these focal discharges seem­
ed present, although bearily observable. Of 3 seizures 
— seizures occurred only in the group of 5 rats — one 
was primary generalized, while in the others the primary 
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or secondary generalized nature was hard to distinguish. 
No focal seizures could be evoked. 
5-methylTHF in rats with a cortical heat lesion and a 
partial hepatectomy 
In a group of 7 rats with a k hour-old cortical heat 
lesion and a partial hepatectomy (the remaining liver va-
ried from 37 - 73%) 5-methylTHF was injected I.v. under 
EEG-record ing in doses varying from 5 - 13 mg. In 4 ani-
mals, 5 primary generalized seizures were observed. 
Neither focal discharges nor focal and secondary gene-
ralized seizures were observed. 
(lntra)cortica1 application of 5-methylTHF in normal rats 
With an i.cort. injection of 5-methylTHF with a micro-
injector primary generalized discharges and seizures were 
distinctly seen, but 5-methylTHF in powder form springled 
on the visible intact cortex evoked mainly focal discharges 
and focal seizures, also with a clinically clear focal cha-
racter. Because of Insufficient technical possibilities 
these experiments were discontinued. 
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Summary 
5-MethylTHF ¡.cist, in normal rats induced generalized 
tonic-clonic seizures alternating with psychomotor distur-
bances, but these epileptic phenomena were nullified by a 
high i.V. dose of DPH. 
5-MethylTHF i.v. in normal rats induced paroxysmal bi-
lateral synchronic discharges and primary generalized sei-
zures in doses, which were much lower than those of folic 
acid (^ 5 - 125 mg i.v., found by Obbens, 1973 and Hommes 
and Obbens, 1972). 
Activation of a cortical heat lesion by 5-methylTHF i.v. 
yielded no apparent focal epileptic phenomena. 
Partial hepatectomy did not inhibit the epileptogenic 
action of 5-methylTHF i.v. 
It therefore seems possible to conclude that 5-niethylTHF 
is responsible mainly for generalizing epileptic activity 
and as such is more effective that folic acid. On the other 
hand. If it has the sufficient properties to provoke focal 
epileptic activity, this is usually obscured by simultane-
ously occurring generalizing epileptic activity. Maybe the 
difference in the epileptogenic activity of folic acid and 
5-methylTHF in the focal folate epilepsy model (folic acid 
evokes focal, but 5-methylTHF evokes generalizing epileptic 
activity) is dependent on the measure of converting of fo-
lic acid Into 5-methylTHF. 
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C H A P T E R 15 
THE INFLUENCE OF FOLIC ACID ON THE KINETIC BEHAVIOUR OF DPH* 
In the medical field of literature, only a few articles 
have been published concerning the influence of folic acid 
on DPH metabolism. Kutt et al (I966) observed an accelera-
ted metabolism of DPH to p-HPPH by folic acid In a DPH-
intoxicated patient. Olesen and Jensen (1970) found a de-
crease of MX in the mean p-HPPH output and a correspond-
ing fall in the serum DPH level in men during daily admi-
nistration of 20 mg folic acid for 5 months. Also Baylis 
et al (I97I) observed decreased DPH levels in serum after 
a 1 month treatment with 15 mg folic acid and also after 
a few weeks administration of 5 mg folic acid, without an 
Increase in the fit frequency. Spaans (1971) could not de-
monstrate in a double-blind study an influence of folic 
acid on the DPH level in serum and CSF. The DPH half-life 
remained unaltered after high doses of folic acid to epi-
leptic patients without a folate-deficlency (Andreasen et 
al, I97I). Reynolds et al (1971) observed a negative corre-
lation between folate and DPH levels in serum, while a si-
This study was performed in collaboration with P.J.M. 
Guelen, A. van Wissenburg and Dr. T.B. Vree from the De-
partment of Clinical Pharmacokinetics. 
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milar but less significant relation was found in the CSF. 
In our study (chapter 12), the rats were orally treated 
with 25 mg DPH daily, for 1 month (exp. ПЭ1»)· An injection 
of 60 mg folic acid was given i.v. after the 30 min. EEG-
recording to induce a stronger seizure activity, but in the 
following 30 min. EEG-recording only a slight increase in 
the seizure activity was seen. So, after an hour recording-
time, blood samples were collected for DPH determinations. 
This showed that the DPH plasma levels were 2 - 3 times lo­
wer in comparison to the control values, suggesting that the 
DPH kinetics are more influenced by folic acid than were ap­
parent from earlier published literature. 
In the following experiments the influence of folic acid 
on the kinetic behaviour of DPH was studied. 
A. The rats were given a dosage of 50 mg DPH-Na orally per 
day for 1 month. It was assumed that these high doses of 
DPH-Na would give a steady mean plasma concentration as well 
as a homogeneous distribution of DPH all over the body. On 
the day of experimenting 30, 75 or 150 mg folic add was 
injected i.V., 1 hour after the last oral DPH-Na admini­
stration. Control rats received the same amounts of DPH-Na 
over the same period without folic acid. Over a 2k hour pe­
riod, the rats were killed under aether-anaesthesia, one 
every ^5 min., starting directly after the folic acid in­
jection. Plasma, whole blood, liver and brain were used 
for analysis. The results obtained with the chronic DPH-Na 
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administration were compared with those of rats receiving 
a single DPH-Na dose (12.5 mg i.v. or 50 mg orally) and 
75 nig fol ic acid i .v. 
The influence of folic acid on the plasma protein bind-
ing of DPH was studied in vitro with equilibrium dialyses 
according to the method as described by Lunde et al (1970) 
and Lund et al (1972). Rats were injected with 75 mg folic 
acid i.v. and plasma samples were collected 1 hour later. 
Samples of O.k ml plasma were dialyzed overnight against 
a physiological buffer solution containing 2 mg/ml C-
labelled DPH. As reference, clear rat plasma was used. 
Resu]ts 
Control rats,treated chronically with 50 mg DPH-Na oral-
ly, demonstrated a zero-order elimination pattern of DPH 
plasma clearance (fig. 2k). A long half-life (approximate-
ly 2^ hours) appeared during the first 18 hours after ad-
ministration, after this time period a faster elimination 
was observed ( a half-life of k hours). An i.v. injection 
of 75 mg folic acid, 1 hour after the last oral DPH admi-
nistration, caused a rapid change in the plasma clearance 
of DPH from a zero-order to a first-order elimination pat-
tern. 
In the same control rats, a clear relationship between 
plasma and brain or liver (called Tissue Partition Coeffi-
cient: TPC) was also measured independently from the height 
of the plasma level and thus independent from linear or 
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D 1 P H E N Y L H Y D A N T O I N 
PLASMA CONCENTRATION IN RATS AFTER CHRONIC ORAL ADMINISTRATION 
Plasma cone ( ^ 5 / ^ 1 ) 
50 
10 
5 
1 -
0 4 8 12 16 20 24 28 
Hrs a f t*r last dose 
Fig.24 Plasma concentration /time curves of DPH in a control group of rats ( treated for 
1 month with 50 mg DPH orally/day ) and an experiment group of rats ( also treated for 
1 month with 50 mg ΟΡΗ orally/day plus 75 mg folic acid i.v.administered directly after 
the last DPH dose). 
non-Ппеаг kinetics (fig. 25 and 26). However, after the 
75 mg i.V. folic acid injection, the IPC's of liver and 
brain increased twofold and threefold respectively with 
regard to plasma, corresponding to the relative lipoid na­
ture of the tissue. The brain accumulated more DPH than 
the liver after the i.V. folic acid injection, resulting 
in an alteration in the brain-liver TPC when compared to 
the control group (fig. 27). 
These above described alterations in plasma half-life 
and TPC's of DPH after injection of 75 mg folic acid I.V. 
also occurred with the same results after a dose of 30 or 
150 mg folic acid (table 19)· 
PARTITION OF DPH OVER P L A S M A - T I S S U E IN RAT5 
A F T E R CHRONIC ORAL ADMINISTRATION 
0 \ ι ι ι ι ι ' 
0 10 20 30 40 50 
C
 bra.n^s/s) 
C
 plasmai m&^ 
0-1 1 1 1 1 1 , , ! ,-1 
0 40 80 120 160 
C l-ver ( K g / g ) 
Fig. 25+26 Partition of DPH between rat plasma and liver or brain after chronic oral 
treatment of 50 mg DPH/day and the increase in the DPH tissue partition coefficients 
(T.P.C.'s ) after a single folic acid injection. 
TISSUa^PARTION COEFFICIENT BETWEEN LIVER AND BRAIN 
IN RATS AFTER CHRONIC ORAL ADMINISTRATION 
Cbnam (MS/S) 
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Fig.27The change of the DPH partition between the liver and brain in rats with 
folic acid administration after chronic oral treatment with 50 mg DPH/day. 
ORAL ABSORBTION AFTER A SINGLE DOSE 
OF 50 rng DPH IN RATS 
4 5 6 
hrs after DPH ingestion 
Fig.28 Absorption of 50 mg DPH in rats after a single oral dose. 
The amount of DPH in the body compartments not being in balance and the DPH 
being still in the distribution phase ; the absorption time is much larger than 
after chronic treatment. 
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A single oral dose of 50 mg DPH-Na showed the same non­
linear clearance pattern as seen after chronic treatment 
with 50 mg ΟΡΗ-Na, but was preceded by a slower absorption 
phase of ΟΡΗ (fig. 28) due to Incomplete distribution in 
the body. After an injection of 75 mg folic acid I.v. the 
absorption phase was more rapid, while a slight change in 
liver-plasma TPC occurred, although less significantly 
(fig. 29). 
In rats with a single dose of 12.5 mg DPH-Na, only a 
slight decrease in the DPH plasma clearance was observed 
during the first 6 hours after 75 nig folic acid I.v. 
P A R T I T I O N OF DPH OVER P L A S M A - L I V E R IN R A T S 
AFTER SINGLE ORAL ADMINISTRATION 
C p l a s m a f r V ' ) " ' 
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C
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Fig.29Partition between plasma and liver after a single dose of 50 mg DPH. 
The change in the T.P.C, after folic acid administration is less than that in 
chronic DPH treatment. 
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В. The results of the DPH plasma protein binding study in 
vitro are summarized in table 20. It can be observed that 
a single dose of 75 rng folic acid i.v. has no influence on 
the in vitro plasma protein binding of DPH compared to con­
trol values without folic acid. 
amount 
fol le acid 
(mg) 
0 
(control) 
30 
75 
ISO 
1¡ver/plasma 
5.0 
9 . 5 
10.0 
9 . 8 
brain/plasma 
1.1 
3 .0 
3 .1 
2 .8 
whole blood/ 
plasma 
3.9 
8 .1 
-
7-5 
braln/1Iver 
0.22 
0.32 
0.31 
0.29 
whole blood/ 
plasma 
0.78 
0.85 
-
0.76 
Table 19 Influence of various closes of ¡.v. folic acid on the tissue 
partition coefficient of diphenylhydantoin in rats chronically treated 
with daily oral dose·: 50 mg DPH. 
Mean 
S.D. 
N. 
Control Rats 
% bound 
80.7 
2.3 
10 
Fol ¡с A d d t r e a t e d Rats 
% bound 
8 1 . 3 
3 . 1 
10 
Table 20 Protein binding of DPH in vitro to rat plasma and the influence 
of folic acid. 
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Summary 
A single dose of 30, 75 or 150 mg folic acid I.v., 1 
hour after the last DPH-Na administration to rats chro-
nically treated with 50 mg oral DPH-Na, caused a change 
In the DPH plasma clearance from a zero-order to a first-
order elimination pattern, while the TPC's of liver and 
brain increased twofold and threefold respectively with 
regard to plasma. The increment in brain DPH content was 
more pronounced, resulting in an alteration in the mutual 
TPC of brain and liver. 
The same results were observed in rats with a single 
oral dose of 50 mg DPH-Na and 75 mg folic acid i.v. 
No influence of folic acid on the in vitro plasma pro-
tein binding of DPH was observed. 
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C H A P T E R 16 
FOLIC ACID AND DPH- INTOXICATION (exp . 1222) 
.!Dír2ííy£Sl2D.í_!!??íb2^§_aníL!r§Í?r.Í3lS.i_ref ylí§ 
In the preceding experiments (chapter 15) the tissue DPH 
content (especially that of the brain) showed a marked in-
crement under the influence of folate resulting in changed 
TPC's. This suggests that a DPH-intoxication in rats can 
be clinically aggravated when folic acid is given. This ex-
periment was set up to study the effects of variable daily 
doses of folic acid (5 - 200 mg i.p.) on fixed daily into-
xicating doses of DPH (100 mg orally) with regard to the 
survival-time of the rats involved. 
Simultaneously, the effects of variable daily doses of 
DPH (3 - 30 mg orally) on fixed non-intox i cat ing daily doses 
of folic acid (30 mg i.p.) were studied. The survival-time 
(in days) of each rat was noted. 
It was observed (fig. 30) that in the group with fixed 
DPH doses, a relatively low dose of folic acid was enough 
to induce a strong decrease in survival-time compared to 
the 'controls', only receiving DPH and having symptoms of 
severe DPH-intoxication and severe folate-deficiency. How-
ever, a very small daily dose of 5 nig folic acid did not 
aggravate the DPH-intoxication, whereas these rats were 
also clinically in a better condition when compared to 
the 'control s'. 
In the group with fixed folic acid doses (fig. 31) rela-
ion 
200 
im 
100 
100 
so 
IOC 
40 
100 
M 
im 
20 
100 
10 
loo орн 
i FZ 
Fig.30 Survival-time ( days ) after fixed doses of DPH orally ( 100 mg/day »and 
varying doses of folic acid i.p. ( 5 - 2 0 0 mg/day ). 
» FZ 
Fig.31 Survival-time ( days ) after fixed doses of folic acid i.p. ( 30 mg/day ) and 
varying doses of DPH orally ( 3 - 3 0 mg/day ). 
1Í»1 
tive low doses of DPH were also enough to induce a strong 
decrease in survival-time compared to 'controls', which 
received folic acid and had clinically a normal condition. 
In both groups, a rapidly aggravating ataxia was the 
most pronounced symptom when the dosage of DPH or folIc 
acid was increased. 
Summary 
A very small dose of folic acid I.p. (5 mg/day) did not 
aggravate the Intoxication, induced by 100 mg DPH orally/ 
day, whereas Increasing doses of folic acid precipitated 
this DPH-intoxication . 
Increasing non-intoxicating DPH doses became intoxi-
cative when combined with high innoxious doses of folic 
acid. 
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C H A P T E R 17 
DISCUSSION 
655aï5_§D^_lfyçl5_2f_rfΪ_^Ε§2η_fojates 
Our microbiological assay method (chapter 8) varied essential­
ly from that used by McClain and Bridgers (1370): in their as­
say, McClain and Bridgers used fresh human plasma as gamma-
carboxypeptidase donor, but the pH- and temperature-optimum 
of this enzyme is different from that of chicken pancreas 
gamma-carboxypeptidase, which was used by us. Besides this, 
McClain and Bridgers 'incubated' the brain suspensions for 
30 min. in a 75 С waterbath to destroy the endogenous gamma-
carboxypeptidases. From our experimental rat brain suspen­
sions, an extraction period of exactly 2 min. with a 7.8 pH 
buffer in a boiling waterbath yielded much higher brain fo­
late contents (+ 1.3 ng/mg w.w.). We found that when this 
period of heating was prolonged, these brain folate con­
tents decreased rapidly to the level found by McClain and 
Bridgers (+ 0.2 ng/mg w.w.). Therefore, during the 30 min. 
period used by McClain and Bridgers, most of the endogenous 
folates were destroyed. 
Thus we concluded that the brain folate values (chapter 
9 ) , determined by our assay method, are more accurate than 
those given by MClain and Bridgers. 
It must also be pointed out that the used assay method 
is a critical factor for the accuracy of the conclusions 
drawn from the plasma/serum and tissue folate levels. In 
H» 3 
mammalian tissues, the folates are mostly of the folylpoly-
glutamate type, having more than three glutamylresidues 
(especially methylated folylpentaglutamates), the remainder 
being oligoglutamates with three or less glutamylres¡dues. 
Semiquantitative chromatographics on DEAE or TEAE cellulose 
(Shin et al, 1972; Thenen et al, 1973) show that the oligo-
glutamate fraction consists mainly of the monoglutamate 
type. Therefore it is assumed that the difference between 
L.casei and S.faecal is activity before treatment with gamma-
carboxypeptidase is a reliable measure for the content of 
methylated folyl monoglutamates (5~fnethylTHF). 
Because of the presence of gamma-carboxypeptidase in mam-
mal ian plasma/serum, no circulating folylpolyglutamates will 
be found. The circulating folate derivative, which physiolo-
gically enters the brain and CSF, is 5-methylTHF. Levitt et 
al (I97I) supported evidence that when labelled doses of fo-
lic acid, 5-formylTHF or 5-methylTHF were given to dogs, only 
the methylated derivative was preferentially taken up into 
the spinal fluid and that the other congeners were converted 
extraneural 1 y to this compound before uptake. When high un-
phys¡ological doses of folylmonoglutamates (other than 5-me-
thylTHF) are injected i.V., It is very likely that these sub-
stances are reduced and methylated before penetrating the 
brain and CSF. After injection of high doses of folic acid, 
5-formylTHF or 5~methylTHF i.p. (no amounts were mentioned), 
only the brain folate levels — determined immediately after 
the folate injection and seizure threshold test — were 
higher In the animals receiving 5-methylTHF (Smith and Farn-
ham, 197Ό. 
liti» 
Besides this, chemical i.v. injected folates are capable 
of expelling physiological folate from its tissue bindings 
into the blood; the derivative is very likely 5~methylTHF 
(see chapter 5)· 
Under physiological conditions, the amount of folic acid 
in the mammalian body is negligible; when folic acid is ad-
ded to the diet, containing natural food folates (mainly 
methylated polyglutamates), this compound will be converted 
in the gut wall into formylated and methylated derivatives 
(Chanarin and Perry, I969)· 
In our experiments, dietary folic acid supplementation lowers 
the cerebral folylpolyglutamate level in rats. A vitamin B12 
and methionine deficient diet seems to have the same effect.lt 
was observed that both special diets induced an increase in 
the cerebral 5-methylTHF content. Blair (1970) suggested 
that folic acid in high doses inhibits its own enzyme sys-
tem. However, Lavoi e et al (137^) demonstrated a folylpoly-
glutamate synthesis from administered folic acid in vitro 
in human vitamin B12-deficient leucocytes, these having in-
creased 5-methylTHF and decreased folylpolyglutamate levels. 
Our unpublished highly elevated folylpolyglutamate liver va-
lues from dietary folic acid supplemented rats (exp. 
II78) supports the finding of Lavoie et al, but it must 
also be pointed out that the brain receives only 5"niethyl-
THF. Therefore we suggest that not only the findings of La-
voie et al are correct for extraneural tissues, but that an 
elevated cerebral 5-methylTHF content probably inhibits the 
folylpolyglutamate synthetase in brain. 
The influences this inversed ratio between folylmono-
1^ 5 
and folylpolyglutamate levels has on the cerebral metabo-
lism, is still unknown. Further research will be necessary 
to study this interesting phenomenon in more detail. 
Conditions for the application of profile analysis may 
be not completely fulfilled. Therefore no definite conclu-
sions could be drawn about the protective action of dietary 
folate-withdrawal against megimide-induced seizure duration. 
Several other points are important in this respect: 
- between the first and second seizure, megimide was in-
jected i.p. with the purpose to test this method of in-
jection, but we found that this experimental approach re-
sulted in the rapid death of several animals in the folate-
deficient and control groups, so it was discontinued. The 
folic acid supplemented group was not injected. So profile 
analysis was only possible between the fully comparable 
folate-deficient and control groups. 
- during the period of experimenting, the number of rats 
in each group decreased because of the death rate involved. 
- during the period of experimenting, the injected doses of 
megimide became markedly different, because of the widely 
divergent body weight between the folate-deficient and 
the other two groups. 
- because of the high folate storage, notebly in the liver 
of the rat, a protective action of dietary folate-withdra-
wal against seizures can be expected after about 6 months. 
- a habituation, resulting in decreasing seizure duration, 
by repeatedly seizure evoking was illustrated in the con-
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trol group (fig. 5). Cabreéis (1970) claimed the oppo-
site. The question remains if this habituation occurs 
equally for the 3 groups. 
- the duration of the seizures within each animal was wide-
ly divergent. 
From the profile analysis we found that there was a weak 
indication that dietary folate-withdrawal affords protec-
tion against megimide seizures. At seizure 12 a signifi-
cant decrease was found in the seizure duration of the 
folate-deficient group, despite an overloading dose of 
megimide in comparison to both other groups. Moreover, 
intraperitoneal folate addition increases the duration 
of megimide seizures. 
The positive correlation of seizure duration and 5~me-
thylTHF in brain makes it very likely that the effects of 
the several diets on seizure duration can be explained by 
the effects they have on the brain levels of 5"methylTHF. 
The convulsant mechanism of megimide and pentetrazole re-
mains still unknown, but for pentetrazole a direct synap-
tic action on excitatory synapses is suggested (see Purpu-
ra et al, 1972); the actions of megimide should be quite 
comparable to those of pentetrazole. 
Mayersdorf et al (1971) reported normal folylmonogluta-
mate levels in the cobalt-epileptogenic foci of cats, 
whereas the folylpolyglutamate level was lowered at the 
cobalt focus and elevated at the mirror focus. No corre-
lations were reported in the literature between cobalt-
epileptogenic phenomena and brain folate levels. 
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Because ail the plasma/serum folate values are influenced 
by dietary circumstances, the positive correlations between 
L.casei, S.faecal is and L.casei minus S.faecal is activity 
and seizure duration are not thought to be in contradiction 
with the above given explanation. From all the folate deri-
vatives, 5~methylTHF is the only which enters the brain and 
CSF from the bloodstream. 
Assuming that the same changes in brain folate levels oc-
curred in the rats of the pentetrazole threshold experiment 
after different dietary folate circumstances, it is very 
likely that the cerebral amount of 5-methylTHF also deter-
mines the susceptibility for pentetrazole-induced epilepto-
genic phenomena. Smith and Racusen (1973) observed no influ-
ence of changed dietary folate contents on the fluothyl-in-
duced first (myoclonic) and second (seizure) thresholds. Al-
though these diets (duration 10 weeks) caused a decrease in 
the serum folate content, the cerebral 5~methylTHF content 
probably did not change because the duration of the diets 
was too short. Lacy and Smith (1973) observed no influence 
of 12 mg folic acid or 5-formylTHF/kg/day i.p. on fluothyl-
Induced seizure thresholds, but they also did not mention 
the duration of folate administration. Our findings support 
the results of Baxter et al (197*0, who observed an increas-
ed incidence of hind-limb extension in electroshock threshold 
studies by subconvulsive doses of folic acid i.ventr. or i.v. 
while folic acid i.ventr. precipitated audiogenic seizures. 
The decrease of both pentetrazole thresholds in the se-
condary folate-deficiency induced by dietary withdrawal of 
vitamin B12 and methionine, also supports the suggestion 
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that the amount of cerebral 5-methylTHF determines the sus­
ceptibility for pentetrazo le-induced epileptogenic phenome­
na: in these rat brains, an elevation of 5-methylTHF was 
found. The fact that no change in meg im i de-induced seizure 
duration occurred in these rats, is very likely due to the 
short duration of the diet (3 months), resulting in un­
changed cerebral 5-methylTHF levels. 
The mediating role of S-methylTHF in megimide- and pen-
tetrazole-induced epileptogenic phenomena is further sup­
ported by the effects of partial hepatectomy/portal vein 
ligature, DPH and SAM on a folate-activated cortical heat 
lesion and the independent epileptogenic activity of 5~ 
methylTHF. 
In these experiments,it was demonstrated that partial 
hepatectomy or portal vein ligature inhibits the generali­
zation of epilepsy. It was also demonstrated that this ef­
fect depends on the amount of liver removed. The only ex­
planation being that the liver produces a factor that con­
trols the generalization of epilepsy. Since it is well-
known that folic acid is converted by the liver to 5~niethyl-
THF (see Blakley, 1969; Bertino, 1971), it is most likely 
that the inhibition of 5-methylTHF production by ligature 
of the portal vein or partial hepatectomy explains these 
findings. 
Because it is known that SAM inhibits in vitro the folate-
reductase system in liver cells via a feedback mechanism 
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(Kutzbach and Stokstad, 1967), the generalization-Inhibitory 
action of SAM (given in high unphysiological doses) can also 
be explained by the Inhibition of the 5-methylTHF production 
from injected folic acid. 
The observed effects of DPH on seizure activity from a 
folate-activated cortical heat lesion were similar to those 
of a partial hepatectomy, portal vein ligature and SAM. The 
DPH effects on folate epilepsy can be explained In the fol-
lowing ways: 
- DPH affects the production of 5-methylTHF extraneurally, 
thereby secondarily decreasing its brain content. This Is 
suggested by Levitt et al (1971), Lacy and Smith (1973) 
and Smith and Farnham (197^). The site of action is most 
Iikely the 1 iver. 
- DPH not only inhibits the folate-reductase system in the 
liver, but also counteracts the epileptogenic action in 
the brain. 
The inhibition of the epileptogenic action of i.cist. in-
jected 5-methylTHF by DPH strongly supports the latter theo-
ry-
It is not fully obvious why Obbens (1973) could not find 
an inhibition of DPH on folate-Induced epilepsy. Probably 
Intracortical administration of folic acid is a method, 
not sensitive enough to make detection of DPH effects pos-
sible. The same holds for her methods of focal heat lesion 
activation. 
MTX and PM did not show inhibitory effects on seizure-
activity from a folate-activated cortical heat lesion. The 
ineffective inhibition of the enzyme dihydrofolate-reduc-
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tase is very likely due to a disproportionate competition 
between the high dose of folic acid and the very low dose 
of MTX/PM for the binding on dihydrofolate-reductase. More-
over, the epileptogenic properties of MTX (Obbens, 1973; 
Hommes and Obbens, 1973) and PM might play an important 
role. 
Finally, all these experiments strongly stress the role 
of 5"methylTHF In generalizing epileptic activity. This ef-
fect of 5~methy1THF was directly tested by i.V., i.cist. 
and i.cort. application (chapter I M and fully confirmed. 
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The observed influence of folic acid administration on 
the kinetic behaviour of DPH may be caused by an interac-
tion of one or more of the following kinetic processes: 
- possible interference of folate with the protein bin-
ding of DPH through which a higher free DPH concentra-
tion in the plasma appeared, which is free unbound DPH, 
easily transported from the plasma into the tissues. 
- stimulation by folate of the enzymes which are respon-
sible for the metabolism of DPH. The Vmax. of the en-
zymes increases and thus the total body clearance of 
DPH increases. 
- increase of the relative distribution volume of DPH un-
der the influence of folate. The DPH will be redistri-
buted all over the body and the DPH plasma concentration 
comes under the Km value. Therefore the nature of the 
clearance changes from zero- to first-order kinetics 
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[ton is the concentration in the plasma at which half of 
the enzymes are occupied. For DPH approximately ]h.k 
mg/1 (van Gìnneken et al, 1971*) J 
As shown in table 21 the influence of folate on the DPH 
protein binding is negligible in vitro experiments under 
physiological conditions. Even if the decrease in protein-
binding was found to be larger, it could not explain the 
dramatic change in the kinetic behaviour of DPH. 
DPH is mainly metabolized by the enzyme cytochrome 
Р-*»50 to p-HPPH and shows so-called non-linear kinetics 
(van Ginneken et al, 1971«; Vree et al, 1975). Theoreti­
cally, the plasma concentration in steady state situations 
can be calculated according to van der Kleyn et al (1975) 
with the equation: 
k . Km 
C t = * 
тах.Д - k 0 
Fig. 32 shows the calculated plasma concentration (C ) 
with various input rates (k-), when the Michaelis Menten 
Constant (Km), the enzyme capacity (Vmax) and the relative 
distribution volume (Л ) are normal. The influence of an 
increase or decrease of the Km value is notícable but less 
dramatic than a similar kind of change in the relative 
distribution volume, calculated with a fixed enzyme capa-
city (fig. 33). Also it is highly improbable that the en-
zyme capacity of cytochrome P-450 increases 200 - 300% 
within one hour, the increase which is necessary to ob-
tain the effects found in this experiment. However, even 
if there is a slight change in the relative distribution 
b
m
 = 20 
I N F L U E N C E OF VARIABLE к,,, O N P L A S M A 
L E V E L S IN N O N L I N E A R K I N E T I C S 
se 
4В 
32 
24 
0 0Θ 0 16 0 24 0 3 2 0 4 0 
Fig 32Calculation of the plasma concentration (Cj ) with the aid of the equation 
mentioned m the discussion, using various K0 rates ( 0 08 - 0.40 mg/kg/hr I and 
a fixed relative distribution volume ( Д ) of 0.72 l/kg. Ct is calculated for 3 different 
Km values 20 0, 14.4 and 8.0 mg/l. 
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Fig33 Calculation of the plasma concentration ( Ct ) with the aid of the equation 
mentioned in the discussion, using various K0 rates ( 0.08 - 0.40 mg/kg/hr.) and 
a fixed Krn value of 14.4 mg/l. C. is calculated for 4 different relative distribution 
volumes: 0.5, 0.72, 1.0and 1.5 l/kg. 
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volume of DPH, which is realistic when looking at the in­
crease in tissue partition coefficients we found in rats, 
the plasma DPH concentration falls rapidly (fig. 33). 
So the cytochrome P-^SO has to react with a smaller DPH 
concentration in the plasma, which Is probably lower than 
the Km concentration. The saturation kinetics is raised 
and the DPH is eliminated from the plasma according to a 
first-order process. These findings led to the hypothesis 
that either high doses of i.v. folic acid or one of its 
derivatives has a membrane-regulating function. This mem­
brane-regulating function consists of the fact that higher 
serum folate levels permit a higher tissue level of DPH. 
In contrast, lower serum folate levels might decrease the 
tissue level of DPH, a subject that we have in study now. 
The adverse influence of high doses of folic acid on DPH-
intoxication supports the hypothesis that high serum fola­
te levels permit a higher tissue level of DPH. Probably 
because the daily doses of 5 Щ folic acid i.p. are too 
small for a clinically visible influence on an aggrava­
tion of the DPH-intoxication but high enough to prevent 
a DPH-induced secondary folate-deficiency, the favourable 
influence of these very small doses on the condition of 
rats treated with intoxicating doses of DPH might be ex­
plained. 
At the end of this study we are faced with two types of 
interaction between folic acid and DPH. The first is the 
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antiepilept ie effect of DPH that may be produced by its in-
hibitory action on the extraneural production or intracere-
bral action of 5-methylTHF, a folate derivative that has 
epileptogenic properties. The second is the role that folic 
acid plays in the tissue distribution of DPH. It is of 
course possible that these two aspects are completely in-
dependent, but this seems very improbable. We strongly fa-
vour a unitary explanation for both of these phenomena. 
To approach such an explanation, further study of the role 
of 5"methylTHF in metabolism, especially that of the brain, 
has to be done. However, some very important recent findings 
may shed some light on this. 
Till now it was assumed that the highly relevant step of 
methylation of the biogenic amines occurred by methyltrans-
ferases in the presence of SAM as the coenzymatical methyl-
donor. Recent findings however demonstrated that 5~methylTHF 
is more important than SAM (Leysen and Laduron, 1971*; 
Mandel 1 et al, 1971»; Laduron, 1973). 
Thus a very important place of 5-methylTHF in brain meta-
bolism is demonstrated and it sheds new light on the fin-
dings reported in this thesis. The strong epileptogenic 
action of 5"methylTHF could mean a direct influence of this 
coenzyme on transmittor substances. Findings of Bridgers 
and McClain (1972) confirmed that most of the 5-methylTHF 
in the brain is located in the synaptosomal fraction. Our 
findings should then indicate that 5-methylTHF activates 
the transmittor-1 ike activities at the synaptosomal junc-
tion. If methylated transmittor substances have an epi-
leptogenic activity, this would explain the role of 
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5-methylTHF in en iIpptonenpsi s. The hypothesis may be even 
more inclusive by the suggestion that the membranal trans-
port of biogenic amines is easier in the methylated form. 
This increased membranal transport of methylated trans-
mi ttors might be the reason for their stronger and even 
for their epileptogenic transmitter action. 
Our own findings showed that folic acid produces a re-
partition of DPH, especially for brain and liver. Certain-
ly,membranal transport of DPH must be involved to explain 
this phenomenon. Using the same assumption as for trans-
mittor substances, methylation of DPH might increase its 
membranal transport. It is suggested here that 5-niethylTHF 
is coenzymatica11 y active in the methylation of DPH. For 
transmitter substances and DPH, the same methylation hypo-
thesis is suggested. 
In chapter 5 several proposals from literature for the 
action of anticonvulsant drugs have been summarized. From 
those the DPH-stîmulated homocysteine — 5-methylTHF 
transferase and the structural resemblance between anti-
epileptic drugs and fractions of the folate molecule are 
the most interesting phenomena. However, according to our 
methylation hypothesis the methylgroup of 5-methylTHF is 
trapped by DPH, resulting in a decrease of the 5-methylTHF 
level in the body. This would mean a decreased methylation 
of transmitter substances in the synaptosomal fraction. 
Proposing a 'secondary transmittor' function of folates 
for NA and Ach, Spector (1972a) suggested that a sequestra 
tion of membrane-bound calcium by folates would be respon-
sible for this function. The antiepileptogenic drugs then 
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would act by competition with folates for calcium bindings 
sites in the cell membrane, they reported. However, the ob-
served influences of folates on the contraction and tonus 
of cholinergic tissues and on oxygen-consumption of brain 
synaptosomes, heart, ileum, virgin uterus and kidney of 
the rat in the presence of NA (Spector, 1972a and b) might 
be explained by our methylatlon hypothesis. 
158 
SUMMARY 
Many epileptic patients, chronically treated with anti-
epileptic drugs such as DPH, show subnormal serum folate 
levels, while in some cases symptoms of severe folate-de-
ficiency are present. On the other hand, folic acid sup-
plementation for controlling this folate-deficiency might 
increase the number and severity of epileptic seizures. 
In animal experiments, it has been shown that folic acid 
and some of its derivatives have strong epileptogenic ac-
tions. It has also been shown that the efficacy of anti-
epileptic drugs in experimental epilepsies is reduced by 
folates. Though the biochemical backgrounds of these in-
teractions between antiepileptic drugs, folates and epi-
lepsy are still far from obvious. 
In this study, the following experiments were perform-
ed. Firstly, the influences of changed dietary circum-
stances on generalized epileptic phenomena induced by 
meg i mi de and pentetrazole, were studied. Our results 
strongly indicated that dietary folate-withdrawal 
shortens the duration of megimide-induced generalized 
seizures, whereas it appeared that dietary or i.p. fo-
lic acid addition prolongs it. A positive correlation 
was found between the duration of these seizures and 
the level of 5-methy1THF in serum and brain. The first pen-
tetrazole threshold (the calculated dose of pentetrazole 
i.p./kg body weight to induce the first paroxysmal bila-
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teral synchronie discharges in the EEG) was lowered in die-
tary folic acid supplemented rats and elevated in rats on a 
folate-deficient diet, both compared to control values. A 
secondary folate-deficiency, induced by dietary withdrawal 
of vitamin B12 and methionine showed that the first as well 
as the second pentetrazole threshold (the calculated dose 
of pentetrazole i.p./kg body weight to induce the first ge-
neralized seizure) were lowered when compared to control 
rats. In these secondary folate-deficient animals, an ele-
vated level of the 5"methylTHF was found in both blood and 
brain. The brain folate values, found by us, were much 
higher (_+ 1.3 ng/ng w.w.) than those given in previous pu-
blished literature (+ 0.2 ng/mg w. w . ) , due to different as-
say methods. 
Secondly, the effects of changes in the folate metabo-
lism were studied with regard to focal folate epilepsy. It 
appeared that a partial hepatectomy strongly reduced the 
seizure activity from a folate-activated cortical heat le-
sion. This reduction was found to be inversedly correlated 
with the percentage of the remaining liver. The same ef-
fects were found with a portal vein ligature but this time, 
more pronounced. In contrast to MTX and PM, DPH and SAM 
also reduced the seizure activity from such a focus. In 
none of these focal folate epilepsy experiments, suppres-
sion of the activity of the focus itself (generation of 
solitary focal discharges) occurred. PM itself evoked vio-
lent generalized clonic seizures, alternating with psycho-
motor disturbances, but for this epileptogenic action, the 
presence of the liver was found to be necessary. This 
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might be explained by 'flush-out' of tissue folate (very 
likely 5-methylTHF) induced by folate analogues such as PM. 
In the experiments with focal folate epilepsy as well as 
the experiments concerning the influences of changed die-
tary circumstances on megimide- or pentetrazole-induced 
epileptic phenomena, 5-methylTHF is very likely responsible 
for the generalizing epileptic activity. 
This suggestion is strongly supported by experiments in 
which 5"methylTHF solely given in very low doses (i.V., 
¡.cist, and i.cort.), appeared to have an independent ge-
neralized epileptic activity. When a preloading dose of 
DPH i.v. was given, the epileptogenic activity of 5-methyl-
THF i.cist. was completely nullified. Partial hepatectomy 
did not influence the epileptogenic action of 5"methylTHF. 
Finally, the influence of folic acid administration on 
the kinetic behaviour of DPH was studied. It appeared that 
high i.v. given doses of folic acid rapidly lowered the 
plasma DPH level. The tissue partition coefficients of 
liver and brain with regard to plasma increased; the DPH 
accumulation in the brain was higher than that of the li-
ver. Besides this, a DPH-intoxication in rats was more ra-
pidly aggravated when high doses of folic acid were given, 
but very small doses of folic acid had clinically a fa-
vourable influence. It is suggested that these ki-
netic effects are very likely due to a change in the re-
lative distribution volume of DPH by folic acid or one 
of its derivatives and not in the DPH plasma protein bind-
ing or capacity of the enzymes involved in the metabolic 
inactivation of DPH. 
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The generalizing mechnnism of action of 5~methylTHF in epi-
leptogenesis was unknown until now as well as the mechanism 
of action of folate on the kinetic behaviour of DPH. An 
increased methylation of the transmittor substances in 
the synaptosomes is suggested, which would result in an 
increased membranal transport and an increased, perhaps, 
epileptogenic activity of these methylated products. The 
same methylation by 5"methylTHF is suggested for DPH, re-
sulting in its increased membranal transport. The anti-
epileptogenic action of DPH would then consist of decrea-
sing the 5-methylTHF level. 
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SAMENVATTING 
Veel epilepsie patiënten, die chronisch worden behandeld 
met antiepileptica zoals DPH, hebben verlaagde serum folaat 
spiegels, terwijl in enkele gevallen symptomen van 
een ernstige foliumzuur-defieienti e aanwezig zijn. An-
derzijds, wanneer men de deficiëntie behandelt door het toe-
dienen van foliumzuur, zou dit kunnen leiden tot een toe-
name van het aantal en de heftigheid van de epileptische 
aanvallen. Dierexperimenteel blijkt dat foliumzuur en enkele 
van zijn derivaten een sterk epileptogene werking bezitten, 
terwijl de werkzaamheid van antiepileptica in experimenteel 
opgewekte epilepsieën sterk vermindert onder invloed van 
folaten. De biochemische achtergronden van de interacties 
tussen antiepileptica, folaten en epilepsie zijn echter 
nog erg onduidelijk. 
In deze studie werden de volgende experimenten verricht. 
Ten eerste werden de invloeden bestudeerd, welke gewijzigde 
dieet omstandigheden hebben op gegeneraliseerde epilep-
tische phenomenen, die werden opgewekt door megimide of 
pentetrazol. Er waren sterke aanwijzingen dat onttrekking 
van folaten door middel van een dieet de tijdsduur van ge-
generaliseerde megimide aanvallen verkort, terwijl daaren-
tegen extra foliumzuur toediening in het dieet of intra-
peritoneaal deze duur verlengt. Tussen de duur van deze 
aanvallen en de 5-methylTHF spiegel in bloed en hersenen 
werden positieve correlaties gevonden. 
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De eerste pentetrazoì drempel (de berekende dose-
ring pentetrazol i.p./kg lichaamsgewicht voor de eerste 
paroxysmale bilateraal synchrone ontladingen in het EEG) 
was lager in ratten die extra foliumzuur in het dieet 
kregen toegediend, vergeleken bij controle waarden, ter-
wijl onttrekking van folaten in het dieet deze drempel 
verhoogde. Een secundaire fol¡umzuur-defieientie ten ge-
volge van vitanine B12 en methionine tekort in het voed-
sel, verlaagde zowel de eerste als de tweede pentetrrzol 
drempel (de berekende dosis pentetrazol i.p./kg lichaams-
gewicht voor de eerste gegeneraliseerde aanval) vergele-
ken bij controle ratten. De 5-methylTHF spiegel in bloed 
en hersenen van deze ratten met een secundaire fol iumzuur-
def ie ient ie was verhoogd. De door ons gevonden hersen fo-
laat waarden (¿ 1,3 ng/mg w.w.) bleken veel hoger te zijn 
dan de literatuur aangeeft (+ 0,2 ng/mg w.w.), hetgeen 
veroorzaakt werd door verschillen in de bepalingsmetho-
diek. 
Ten tweede werden de effecten van veranderingen Ín 
het foliumzuur metabolisme met betrekking tot focale fo-
liumzuur epilepsie bestudeerd. De aanva1s-acti vi te it van-
uit een door foliumzuur geactiveerde corticale hittelesie 
werd sterk verminderd door een partiële hepatectomie. Deze 
reductie was omgekeerd evenredig met het percentage rest-
lever. Een ligatuur van de vena portae gaf eenzelfde, nog 
sterkere reductie te zien. Diphantoine en S-adenosylmethio-
nine verminderden in tegenstelling tot methotrexaat en 
pyrimethamine ook de aanvals-acti vi teit vanuit een derge-
lijk focus. In geen van deze focale foliumzuur epilepsie 
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experimenten werd de fociis-act i ν i te ! t (bet ontstaan 
van solitaire focale ontladingen) onderdrukt. Pyrimetha­
mine zelf veroorzaakte heftige gegeneraliseerde clonische 
aanvallen, welke afgewisseld werden door psychomotore 
stoornissen, maar de aanwezigheid van de lever bleek nood­
zakelijk voor deze epileptogene werking. Dit zou kunnen 
worden verklaard door een "flush-out" van foliumzuur in 
de weefsels (zeer waarschijnlijk 5-methy1THF) ten gevolge 
van foliumzuur analoga zoals pyrimethamine. In de focale 
foliumzuur epilepsie experimenten alsmede in de experimen­
ten, waarin de invloeden werden bestudeerd die veranderde 
dieet omstandigheden hebben op epileptische phenomenen, 
welke werden opgewekt door megimide en pentetrazol , is 
5-methylTHF zeer waarschijnlijk verantwoordelijk voor de 
generaliserende epileptische activiteit. 
Deze suggestie wordt sterk ondersteund door experimen­
ten, waarin 5"methylTHF zelf in zeer lage doseringen (i.V., 
i.cist. en i.cort.) een onafhankelijke gegeneraliseerde 
epileptische activiteit bleek te hebben. Wanneer tevoren 
een intraveneuze dosering diphantoine was gegeven, werd de 
epileptogene werking van intraci sternaal 5~methylTHF ge­
heel gereduceerd. De epileptogene werking van 5-methylTHF 
werd niet beïnvloed door een partiële hepatectomie. 
Tenslotte werd de invloed van foliumzuur toediening 
op het kinetische gedrag van diphantoine bestudeerd. Hoge 
intraveneuze doseringen van foliumzuur verlaagden in korte 
tijd de plasma diphantoine spiegel. De weefsel verdelings-
coëfficiënten van lever en hersenen ten opzichte van plas-
ma namen toe. De diphantoine stapeling in de hersenen was 
165 
yroter dan in de lever. Hiernaast bleek een diphantoine 
intoxicatie in ratten sneller te verergeren wanneer hoge 
doseringen foliumzuur werden gegeven, maar zeer lage do-
seringen foliumzuur hadden een gunstige invloed op de 
klinische toestand. Oeze effecten worden zeer waarschijn-
lijk veroorzaakt door een verandering in het relatieve 
distributie volume van diphantoine ten gevolge van folium-
zuur of een van zijn derivaten en niet door een verande-
ring in de plasma eiwit binding van diphantoine of capa-
citeit van de enzymen die betrokken zijn bij de metabole 
inactivatie van diphantoine. 
Het generaliserende werkingsmechanisme van 5-methylTHF 
in de epileptogenesis was tot nu toe niet bekend evenmin 
als het werkingsmechanisme van foliumzuur in het kinetisch 
gedrag van diphantoine. Een verhoogde methylering van trans-
mitter substanties in de synaptosomen zou een toegenomen 
membraan transport en een verhoogde, wellicht epilepto-
gene activiteit van deze gemethyleerde producten ten ge-
volge kunnen hebben. Diphantoine zou op dezelfde wijze 
door S^methylTHF gemethyleerd worden, hetgeen zou kunnen 
resulteren in een toegenomen membraan transport van di-
phantoine. De antiepileptogene werking van diphantoine 
zou dan bestaan uit het verlagen van de 5-methylTHF 
spiegel. 
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ABBREVIATIONS 
¡.p. 
¡ . V. 
í.cort. 
i.cist. 
¡.ventr. 
EEG 
CNS 
CSF 
TPC 
¡ntraperi toneal 
intravenous 
intracort¡cal 
intracisternal 
intraventricular 
electroencephalogram 
central nervous system 
cerebro-spinal fluid 
tissue partition coefficient 
Ach 
GA 
GA BA 
NA 
DA 
5-HT 
5-HIAA 
HVA 
DPH 
SAM 
MTX 
PM 
THF 
acetylcholine 
glutamic acid 
gamma-aminobutyric acid 
noradrenaline 
dopamine 
5-hydroxytryptamine 
5-hydroxyindoleacetic acid 
homovani11ic acid 
diphenylhydantoin 
I 
S-adenosylmethionine 
methotrexate 
pyrimethamine 
tetrahydrofolate. 
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